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·4· ·------------------------------------------
·5· ·REYNOLDS AMERICAN, INC.,
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·2· · · · · · · ·(Whereupon, Exhibit 1300, Expert
·3· · · · ·Report of Anil Shivdasani, Ph.D., was
·4· · · · ·marked for Identification, as of this
·5· · · · ·date.)
·6· · · · · · · ·(Whereupon, Exhibit 1301,
·7· · · · ·Rebuttal Report of Anil Shivdasani,
·8· · · · ·Ph.D., was marked for Identification,
·9· · · · ·as of this date.)
10· · · · · · · ·THE VIDEOGRAPHER:· Good morning.
11· · · · ·We are on the record.· The time on the
12· · · · ·monitor is 9:05.
13· · · · · · · ·Today is the 19th day of April
14· · · · ·2019.· We are here at 825 Eighth
15· · · · ·Avenue, New York, New York for the
16· · · · ·purpose of taking the videotaped
17· · · · ·deposition of Dr. Anil Shivdasani in
18· · · · ·the matter of Reynolds American Inc.
19· · · · ·Versus Third Motion Equities Master
20· · · · ·Fund, Limited.
21· · · · · · · ·The videographer is James Soto,
22· · · · ·the court reporter is Joan Ferrara,
23· · · · ·both with U.S. Legal Support.
24· · · · · · · ·All counsel will be noted in the
25· · · · ·stenographic record.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·Please administer the oath.
·3· ·A N I L· ·S H I V D A S A N I ,
·4· · · · · called as a witness, having been
·5· · · · · duly sworn by a Notary Public, was
·6· · · · · examined and testified as follows:
·7· ·EXAMINATION BY
·8· ·MR. SHINDEL:
·9· · · · ·Q· · ·Good morning.
10· · · · ·A· · ·Good morning.
11· · · · ·Q· · ·Do you prefer Dr. Shivdasani or
12· · Professor Shivdasani?
13· · · · ·A· · ·Whichever.· Either is fine.
14· · · · ·Q· · ·When were you first contacted
15· · regarding a potential engagement in this
16· · matter?
17· · · · ·A· · ·I believe it was sometime in the
18· · late summer or early Fall of 2018.
19· · · · ·Q· · ·Who contacted you?
20· · · · ·A· · ·I was first approached by
21· · someone at Cornerstone Research who asked
22· · me about my potential interest and
23· · availability in a matter.
24· · · · ·Q· · ·And what did you say?
25· · · · ·A· · ·I said sure, I'd be interested
·1· · · · · · · · · ·A. Shivdasani
·2· · and available to talk about the matter.
·3· · · · ·Q· · ·And did you talk about the
·4· · matter further with Cornerstone?
·5· · · · ·A· · ·I don't believe -- well, they
·6· · told me sort of the entities involved at
·7· · that time.· I don't recall having any
·8· · substantive conversation beyond sort of
·9· · knowing the entities with Cornerstone.
10· · · · ·Q· · ·What was the first substantive
11· · conversation you had regarding your
12· · engagement in this matter?
13· · · · ·A· · ·I think I had a meeting
14· · subsequently with attorneys at Cravath
15· · where I understood the matter in a little
16· · bit more detail.
17· · · · ·Q· · ·All right.
18· · · · · · · ·What do you understand your
19· · assignment in this case to be?
20· · · · ·A· · ·I understand my assignment is to
21· · conduct an analysis of the efficiency of
22· · the stock for Reynolds in the market, and
23· · as part of that I understood that I was
24· · asked to consider all the factors that
25· · courts have considered in making that
·1· · · · · · · · · ·A. Shivdasani
·2· · assessment, as well as any of my own
·3· · analysis of factors that may prevent public
·4· · information from being incorporated in
·5· · Reynolds' stock price.
·6· · · · ·Q· · ·What areas do you hold yourself
·7· · out as an expert in?
·8· · · · ·A· · ·I'm not quite sure what the term
·9· · hold yourself out as an expert quite means.
10· · · · · · · ·The way I would phrase it is, I
11· · believe I have expertise in financial
12· · economics on issues of valuation, on
13· · financial prices on stock market
14· · efficiency, corporate governance -- I think
15· · the areas in which I have written and
16· · published on in corporate finance.
17· · · · ·Q· · ·And which if any of those areas
18· · are you being offered as an expert at the
19· · trial in this action?
20· · · · ·A· · ·You know, I haven't read the --
21· · I haven't read sort of whatever legal
22· · statements, if you will -- if that's the
23· · right term -- about how I'm being offered
24· · as an expert.· So I don't know.· I believe
25· · I have expertise in financial economics.
·1· · · · · · · · · ·A. Shivdasani
·2· · So I don't know beyond that what has been
·3· · offered in this matter.
·4· · · · ·Q· · ·Do you consider yourself an
·5· · expert in the law of any particular
·6· · jurisdiction?
·7· · · · ·A· · ·No, I do not.
·8· · · · ·Q· · ·Do you have any formal legal
·9· · training?
10· · · · ·A· · ·No, I do not.
11· · · · ·Q· · ·I previously marked as Exhibit
12· · 1300 and placed in front of you what should
13· · be a copy of your opening report.
14· · · · · · · ·Do you have that?
15· · · · ·A· · ·Yes, I do.
16· · · · ·Q· · ·And if you want to flip through
17· · it and just confirm for me that that is, in
18· · fact, a copy of your report with the
19· · relevant indices and appendices.
20· · · · ·A· · ·Yes, it does appear to be.
21· · · · ·Q· · ·Can you turn to Appendix B in
22· · your opening report, which should be the
23· · list of your prior testimony.
24· · · · ·A· · ·Yes.
25· · · · ·Q· · ·Can you identify for me which if
·1· · · · · · · · · ·A. Shivdasani
·2· · any of the matters listed in Appendix B
·3· · resulted in a decision on the merits from
·4· · the Court?
·5· · · · ·A· · ·You'll have to explain to me
·6· · exactly what decision on the merits means.
·7· · It's a term I'm not intimately familiar
·8· · with.
·9· · · · ·Q· · ·Sure.· So either a summary
10· · judgment decision granting judgment for one
11· · side or a post-trial decision.· Basically,
12· · cases that didn't settle.
13· · · · ·A· · ·I don't know if I am aware of
14· · that knowledge for each single one of these
15· · cases.· You know, sometimes cases settle
16· · and I may not be aware of that.· So I can
17· · attempt to give you my best understanding,
18· · but with the understanding that I might --
19· · it may be very incomplete.· If you would
20· · like me to do that --
21· · · · ·Q· · ·Well, is it easier, can you
22· · identify on Appendix B which cases you've
23· · testified at a trial in?
24· · · · ·A· · ·At a trial, certainly.· And I
25· · think for the most part that should be
·1· · · · · · · · · ·A. Shivdasani
·2· · listed in here.
·3· · · · · · · ·So if you look at the list on
·4· · number 11, I did testify in that matter.  I
·5· · don't know if that is technically a trial
·6· · or not, but I did testify in court.· I just
·7· · don't know the correct legal term for the
·8· · context in which my testimony occurred in
·9· · that matter.
10· · · · ·Q· · ·And before you go on, just so --
11· · what was the subject matter of your
12· · testimony in number 11 here, Joan Collins
13· · TDV the Minister of Finance of Ireland and
14· · the Attorney General of Ireland?
15· · · · ·A· · ·The subject matter there was
16· · issues around the financial bailout that
17· · the Government of Ireland had conducted
18· · around the financial crisis and it was with
19· · respect to certain instruments/securities
20· · around the bailout that occurred.
21· · · · · · · ·I testified in trial -- I have
22· · testified in matter number 18 in Fredric
23· · Eshelman vs. Alan Auerbach and Puma
24· · Biotechnology.· That was not at trial, in
25· · sort of during the trial.· I understand it
·1· · · · · · · · · ·A. Shivdasani
·2· · was what was termed a deposition at trial,
·3· · but that was because I could not attend the
·4· · trial.
·5· · · · · · · ·Then I have testified in number
·6· · 19 in Energy Transfer Equity.
·7· · · · · · · ·I've testified in matter 21,
·8· · which was Akorn c. Fresenius.
·9· · · · · · · ·Those are the ones I believe
10· · I've testified in trial.
11· · · · ·Q· · ·The matters you just identified
12· · where you testified at trial either through
13· · deposition or in person, were there any in
14· · which the Court rejected your conclusions?
15· · · · ·A· · ·I'm not sure exactly what you
16· · mean by rejected my conclusions.· So let me
17· · tell you my understanding of that matter.
18· · · · · · · ·So in matter number 18, I
19· · believe my testimony was excluded.
20· · · · · · · ·In matter 21, you know, I don't
21· · recall the term rejected my conclusions,
22· · but the testimony -- I think the opinion
23· · had a footnote that said that my testimony
24· · was not helpful and on one point, on one of
25· · my answers, the judge viewed it not to be
·1· · · · · · · · · ·A. Shivdasani
·2· · credible.· So I hope that answers your
·3· · question.
·4· · · · ·Q· · ·Sure.
·5· · · · · · · ·Do you know why your testimony
·6· · was excluded in number 18, Eshelman v.
·7· · Auerbach?
·8· · · · ·A· · ·Right.· So my understanding is
·9· · part of the decision there had to do with
10· · what was deemed to be relevance, that there
11· · was part of my testimony that was -- part
12· · of the assignment that I was asked to
13· · conduct was excluded on grounds that it was
14· · viewed by the Court to be a matter of fact,
15· · that there was perhaps not an expert
16· · opinion required for that.
17· · · · · · · ·On the second part, it was
18· · excluded because while the judge did not
19· · disagree with the methodology, the view was
20· · that the application of that methodology
21· · did not fit the facts of that case in that
22· · matter.· I respectfully disagree with that,
23· · but that was the opinion.
24· · · · ·Q· · ·And in number 21, Akorn v.
25· · Fresenius, I take it you've read the post
·1· · · · · · · · · ·A. Shivdasani
·2· · trial decision from Vice Chancellor Laster
·3· · in that case?
·4· · · · ·A· · ·I've looked at it.· I haven't
·5· · read the entirety of it, yes.
·6· · · · ·Q· · ·And as I think you noted, he --
·7· · Vice Chancellor Laster concluded that your
·8· · testimony was not helpful and in at least
·9· · one instance was not credible?
10· · · · ·A· · ·That is correct.
11· · · · ·Q· · ·Has a court ever adopted any
12· · opinions you've offered related to market
13· · efficiency?
14· · · · ·A· · ·I'm not sure what you mean by
15· · adopted my opinion.· I don't know what that
16· · means.
17· · · · ·Q· · ·Has a court ever relied on your
18· · opinions related to market efficiency in
19· · reaching a decision in a contested matter?
20· · · · ·A· · ·Well, in matter -- in Energy
21· · Transfer Equity, I did conduct an event
22· · study.· I don't recall whether -- I mean so
23· · event study relies on the presumption of
24· · market efficiency.· I don't recall all the
25· · analysis I did, but I did do an event
·1· · · · · · · · · ·A. Shivdasani
·2· · study, which is a technique that is based
·3· · upon the premise of market efficiency.· And
·4· · my testimony, I believe, was adopted by the
·5· · Court.
·6· · · · ·Q· · ·What was the event study that
·7· · you performed in Energy Transfer Equity
·8· · intended to show?
·9· · · · ·A· · ·It was intended to assess
10· · whether certain financing transactions or
11· · certain financing events, whether it was a
12· · dividend or financing, I don't recall --
13· · they were inter-mingled in that issue --
14· · had an issue on the stock price.· I don't
15· · recall all the details at this time.
16· · · · ·Q· · ·All right.
17· · · · · · · ·If you could turn to page 3 of
18· · your opening report and focus on paragraph
19· · 11.
20· · · · ·A· · ·Yes.
21· · · · ·Q· · ·Is that the sole affirmative
22· · opinion you intend to offer at trial in
23· · this action?
24· · · · ·A· · ·I would say, in essence, yes.
25· · But I guess I would add a couple of other
·1· · · · · · · · · ·A. Shivdasani
·2· · clarifications on this point with respect
·3· · to what's written here or just expound on
·4· · this.
·5· · · · · · · ·So, I mean, I want to make clear
·6· · that these are not just the only words that
·7· · I plan to offer -- but yes, in substance,
·8· · that would be correct.
·9· · · · ·Q· · ·All right.
10· · · · · · · ·And what clarifications would
11· · you intend to offer at trial with respect
12· · to the opinion set forth in paragraph 11 of
13· · your report?
14· · · · ·A· · ·And, obviously, the
15· · clarification that I see that's not present
16· · in 11, but as I expound on later in the
17· · summary of opinions and obviously in my
18· · report is that the form of market
19· · efficiency that I'm referring to is the
20· · semi-strong form and that, collectively,
21· · the points made in paragraph 11 also lead
22· · me to the opinion that there is no evidence
23· · that the market for Reynolds' stock was not
24· · trading in a semi-strong form efficient
25· · market.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·Are you offering the opinion
·3· · that the market for RAI's stock was strong
·4· · form efficient?
·5· · · · ·A· · ·No, I am not.
·6· · · · ·Q· · ·Are you offering the opinion
·7· · that the market for RAI's stock was, in
·8· · fact, semi-strong form efficient at any
·9· · particular time?
10· · · · ·A· · ·So the way I would answer that
11· · is I am offering the opinion that there is
12· · no evidence to reject the hypothesis that
13· · the market was, for Reynolds' stock was
14· · semi-strong form efficient.
15· · · · · · · ·By its very nature, the
16· · efficient market hypothesis is a
17· · hypothesis, and the correct scientific
18· · approach to assessing a hypothesis is to
19· · understand whether or not there is any data
20· · that can be used to reject the hypothesis,
21· · and that's what I've done.
22· · · · · · · ·My report shows that there is no
23· · data that I have uncovered that rejects the
24· · semi-strong form hypothesis for Reynolds'
25· · stock and that, therefore, all the evidence
·1· · · · · · · · · ·A. Shivdasani
·2· · is consistent with that.
·3· · · · · · · ·I hope that clarifies the
·4· · question that you asked.
·5· · · · ·Q· · ·Sure.
·6· · · · · · · ·In paragraph 11, part of what
·7· · you write is that the market for Reynolds'
·8· · stock displayed numerous attributes that
·9· · courts have considered as indicative of
10· · market efficiency.
11· · · · · · · ·Do you see that?
12· · · · ·A· · ·Yes, I do.
13· · · · ·Q· · ·Did you derive the factors that
14· · you assert courts have considered
15· · indicative of market efficiency based on
16· · your personal review of judicial opinions?
17· · · · ·A· · ·I would say yes or no.· I was
18· · aware of certain factors that courts have
19· · used in the past, but I wanted to also make
20· · sure that I was considering all the
21· · relevant factors that courts have
22· · considered and I sought guidance from
23· · counsel on that topic to make sure that I
24· · was not overlooking anything.
25· · · · ·Q· · ·In paragraph 12 of your report
·1· · · · · · · · · ·A. Shivdasani
·2· · you cite three decisions as having
·3· · considered the list of factors regarding
·4· · market efficiency that you characterize as
·5· · having been provided to you by counsel,
·6· · correct?
·7· · · · ·A· · ·That is correct.· That is
·8· · correct, yes.
·9· · · · ·Q· · ·And the three decisions you cite
10· · are the Dell decision from the Delaware
11· · Supreme Court, the DFC decision from the
12· · Delaware Supreme Court, and the Aruba
13· · decision from the Delaware Court of
14· · Chancery, right?
15· · · · ·A· · ·That is correct.
16· · · · · · · ·If I could just clarify, these
17· · were provided to me by counsel, but I had
18· · read some of these opinions or parts of
19· · these opinions even prior to counsel
20· · providing them to me.· But you're correct,
21· · these were provided to me by counsel.
22· · · · ·Q· · ·All right.
23· · · · · · · ·Well, in the first sentence of
24· · paragraph 12 of your report, you write:
25· · "First, market evidence about Reynolds'
·1· · · · · · · · · ·A. Shivdasani
·2· · stock is consistent with attributes that,
·3· · as I understand from counsel, courts in the
·4· · past have considered as indicators of
·5· · market efficiency for an individual
·6· · company's stock," correct?
·7· · · · ·A· · ·That is correct.
·8· · · · ·Q· · ·So are the attributes that you
·9· · go on to list in paragraph 12 all
10· · attributes that were provided to you by
11· · counsel?
12· · · · ·A· · ·Yes, I believe so.· Yes, they
13· · were all attributes that counsel pointed to
14· · me, pointed me to that were considered in
15· · these matters.
16· · · · ·Q· · ·Is your opinion that you're
17· · offering in your opening report dependent
18· · on the Dell decision, the DFC decision and
19· · the Aruba decision?
20· · · · ·A· · ·No, I would not say they're
21· · dependent on those decisions.· I wanted to
22· · make sure that I was not overlooking any
23· · factor that courts have considered in the
24· · past and I sought to, therefore, be as
25· · comprehensive in my analysis as possible.
·1· · · · · · · · · ·A. Shivdasani
·2· · I wouldn't say they're dependent on any
·3· · decision.
·4· · · · ·Q· · ·All right.
·5· · · · · · · ·Well, in paragraph 11, the way
·6· · you frame your opinion is that the market
·7· · for Reynolds' stock displayed numerous
·8· · attributes that courts have considered
·9· · indicative of market efficiency, right?
10· · · · ·A· · ·Right, correct.
11· · · · ·Q· · ·So I'm just trying -- I mean the
12· · way I read that, your opinion is dependent
13· · on, in the first instance, what are the
14· · attributes that courts consider relevant.
15· · · · · · · ·Am I misunderstanding your
16· · opinion?
17· · · · ·A· · ·I guess maybe we're thinking
18· · about different things about dependent on.
19· · · · · · · ·In -- when I was asked to assess
20· · factors that the courts have found to be --
21· · assess factors that courts have considered
22· · indicative of market efficiency, I sought
23· · to assess all of those factors.
24· · · · · · · ·So the way I think about it is
25· · these are factors that courts have
·1· · · · · · · · · ·A. Shivdasani
·2· · considered in the past that the courts have
·3· · found helpful in arriving at their
·4· · determination of whether or not the market
·5· · was efficient for any particular security
·6· · in that matter.
·7· · · · · · · ·What the actual determination
·8· · was in a specific case was not something
·9· · that I focused on.
10· · · · · · · ·So yes, they are dependent on
11· · the fact that the courts have looked to
12· · these factors.· They're not dependent on
13· · the outcome of those court decisions, is
14· · the way I was responding to your question.
15· · · · ·Q· · ·But, for example, if the courts
16· · were to decide that these factors are no
17· · longer relevant, would that change your
18· · opinion?
19· · · · ·A· · ·No, I don't believe -- I don't
20· · believe it would.
21· · · · ·Q· · ·Even though your opinion is
22· · based on what the set of factors that
23· · courts consider indicative of market
24· · efficiency, if the courts changed the list
25· · of factors, that wouldn't change your
·1· · · · · · · · · ·A. Shivdasani
·2· · opinion?
·3· · · · ·A· · ·Well, I want to -- I think maybe
·4· · my previous answer was not clear, so let
·5· · me -- these are factors that the courts, I
·6· · understand, have considered in the past.
·7· · · · · · · ·I have applied my analysis to
·8· · all of these factors.· None of these
·9· · factors, by my analysis, suggested that the
10· · market was behaving in a manner
11· · inconsistent with market inefficiencies --
12· · with market efficiency.
13· · · · · · · ·If the Court at some point
14· · decides in the future that some of those
15· · factors are not relevant, that would not,
16· · therefore, change my opinions.
17· · · · · · · ·Your second question said if the
18· · courts changed the factors in the future,
19· · which I presume to mean they're going to
20· · add new factors, well, obviously I've not
21· · considered those because I am not aware of
22· · those factors.
23· · · · · · · ·I hope that was helpful in
24· · responding to your question.
25· · · · ·Q· · ·That was.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·If you turn to page 8 of the
·3· · report and focus on paragraph 26, and in
·4· · paragraph 26 you quote the Aruba decision
·5· · from the Delaware Court of Chancery as
·6· · follows:· "If a company's shares trade in a
·7· · market having attributes consistent with
·8· · the assumptions underlying a traditional
·9· · version of the semi-strong form of the
10· · efficient capital markets hypothesis, then
11· · the unaffected trading price provides
12· · evidence of the fair value of a
13· · proportionate interest in the company as a
14· · going concern," correct?
15· · · · ·A· · ·That is correct.
16· · · · ·Q· · ·Did you rely on that legal
17· · conclusion in formulating the opinions in
18· · your opening report?
19· · · · ·A· · ·No, I did not.
20· · · · ·Q· · ·Why did you insert an entire
21· · paragraph in your report that just quotes
22· · that legal conclusion then?
23· · · · ·A· · ·I think this is just to provide
24· · context for my report.
25· · · · ·Q· · ·Are you aware that the Court of
·1· · · · · · · · · ·A. Shivdasani
·2· · Chancery's decision in the Aruba case was
·3· · reversed by the Delaware Supreme Court
·4· · earlier this week?
·5· · · · ·A· · ·So I read in the newspaper, a
·6· · newspaper article, in the Financial Times
·7· · there was an article on that.· I did read
·8· · that article.· I haven't read the opinion.
·9· · · · · · · ·So I don't know exactly what was
10· · reversed.· But yes, I had read an article
11· · on this that there was a more recent
12· · Supreme Court ruling that changed aspects
13· · of this ruling.
14· · · · ·Q· · ·But you haven't read the actual
15· · Delaware Supreme Court Aruba decision?
16· · · · ·A· · ·I have not read the Supreme
17· · Court decision on this, on this case, no.
18· · · · ·Q· · ·So you don't know whether the
19· · Delaware Supreme Court decision in Aruba
20· · changed the list of factors that are
21· · relevant in Delaware to evaluating whether
22· · a market is a semi-strong efficient?
23· · · · ·A· · ·Well, certainly I was not aware
24· · of that at the time I wrote my report,
25· · because that decision had not occurred.· So
·1· · · · · · · · · ·A. Shivdasani
·2· · everything that I say in my report is as of
·3· · the time my report was written.
·4· · · · · · · ·And I did not see discussion in
·5· · the Financial Times article that the list
·6· · of factors has changed.· But I haven't read
·7· · the opinion.
·8· · · · ·Q· · ·Paragraph 27 of your report
·9· · lists 10 different factors that you say the
10· · courts in Dell, DFC and the Court of
11· · Chancery in Aruba considered in evaluating
12· · whether the market for the relevant
13· · corporation's stock was efficient, correct?
14· · · · ·A· · ·Yes.· I believe these were the
15· · indicators of market efficiency that the
16· · courts considered.
17· · · · ·Q· · ·And I think we covered this
18· · before, but I just want to be clear when it
19· · comes to these ten specific factors, were
20· · these ten factors provided to you by
21· · counsel?
22· · · · ·A· · ·You know, I know counsel pointed
23· · me to the relevant court decisions that
24· · considered the market, the indicators of
25· · market efficiency.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·I don't know if counsel told me
·3· · here is a list of the 10 factors we want
·4· · you to evaluate.· I don't recall having
·5· · that discussion.· But counsel did provide
·6· · me with a list of the Court decisions and
·7· · these factors were all mentioned in those
·8· · court decisions.
·9· · · · · · · ·So in that respect, that's what
10· · I'm alluding to and referencing to in my
11· · report, that these are the decisions and
12· · that enumerate the factors that I was
13· · asked, being asked to consider.
14· · · · · · · ·So I just want to clarify, I
15· · don't believe counsel ever gave me a list
16· · that we want these 10 things considered,
17· · but they did point me to the Court
18· · decisions that elaborate on these factors.
19· · Some of these I was aware of prior to my
20· · engagement in this matter.
21· · · · ·Q· · ·The list of 10 factors in
22· · paragraph 27, how did you arrive at that
23· · specific list of factors?
24· · · · ·A· · ·Well, I reviewed the Court
25· · decisions, the rulings.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·I think, for the most part, I
·3· · believe I was aware of all of these, or
·4· · certainly I've analyzed some of these
·5· · factors in the past as well, in other work.
·6· · · · · · · ·And so it was a compilation of
·7· · that process and these are the factors that
·8· · I saw that were considered in the Court
·9· · decisions.
10· · · · ·Q· · ·So you read the Court decisions
11· · that counsel pointed you to and your
12· · interpretation of those decisions that
13· · these are, you know, collectively these 10
14· · factors were relevant to the Delaware
15· · Supreme Court and the Delaware Court of
16· · Chancery based on your review of Dell, DFC
17· · and Aruba, is that fair?
18· · · · ·A· · ·Could you repeat that question,
19· · please?
20· · · · · · · ·MR. SHINDEL:· Sure.· Could you
21· · · · ·read it back?
22· · · · · · · ·(Whereupon, the requested
23· · · · ·portion was read back by the Court
24· · · · ·Reporter.)
25· · · · ·A· · ·You know, the way I approached
·1· · · · · · · · · ·A. Shivdasani
·2· · this was when I was asked to consider the
·3· · list of factors that courts have considered
·4· · in the past, I was aware of factors that
·5· · are commonly known as the Cammer and Cammer
·6· · Krogman factors.
·7· · · · · · · ·As part of working on this
·8· · project, I wanted to make sure I was not
·9· · overlooking anything else, and I asked
10· · counsel to point me to any other legal
11· · decisions or rulings that were relevant for
12· · considering the factors that I should be
13· · looking at.
14· · · · · · · ·So I did not attach any
15· · importance to or assessment of this is what
16· · Delaware has found or, you know -- so I
17· · think you asked specifically about
18· · Delaware.· These are the Court decisions
19· · that I was provided with.· I looked at
20· · those and I came up with a list of factors.
21· · · · ·Q· · ·Are you offering the opinion
22· · that the North Carolina Court should
23· · consider these 10 factors in rendering its
24· · decision in this action?
25· · · · ·A· · ·So I am not offering any legal
·1· · · · · · · · · ·A. Shivdasani
·2· · opinions in this matter.· As a financial
·3· · economist, some of these factors obviously
·4· · have a basis and economic theory, and so
·5· · these are not purely legally determined
·6· · factors.· They have their foundations in
·7· · certain economic principles.
·8· · · · · · · ·So, for example, factor J, which
·9· · is whether or not the stock price reacted
10· · quickly to the release of new news, is
11· · considered to be one of the most important,
12· · if not -- one of the most important tests
13· · of market efficiency.
14· · · · · · · ·And so to that extent, if I'm
15· · asked to offer an opinion on what are the
16· · important basis or kinds of analyses to
17· · test or examine market efficiency, I would
18· · offer some of these factors as being
19· · relevant to that, but it is -- obviously,
20· · it's not my expertise to say what factors
21· · the North Carolina Court should consider.
22· · · · · · · ·So I will opine specifically as
23· · a financial economist on what, as I, as a
24· · financial economist, see as factors that
25· · are relevant to the testing of the
·1· · · · · · · · · ·A. Shivdasani
·2· · efficient market hypothesis.
·3· · · · ·Q· · ·And which subset of these 10
·4· · factors are relevant from a financial
·5· · economist's perspective?
·6· · · · ·A· · ·Well, I think that to some
·7· · degree a lot of these factors have some
·8· · degree of relevance.· So I think it's more
·9· · an issue of the degree of relevance.
10· · · · · · · ·Of all of these, I think the
11· · economics and finance professions have
12· · looked at factor J most extensively, and
13· · there is a wide body of literature that
14· · suggests that this is the most appropriate
15· · way to test for market efficiency.· But I
16· · would say that they all have some degree of
17· · relevance to the issue.
18· · · · ·Q· · ·All right.
19· · · · · · · ·Well, as to the 10 factors that
20· · you set out in paragraph 27, it looks like
21· · for each of them you cite to at least one
22· · of, if not all of, the Dell decision, the
23· · DFC decision and the Aruba decision,
24· · correct?
25· · · · ·A· · ·Right.· I believe I was making
·1· · · · · · · · · ·A. Shivdasani
·2· · reference to where my understanding was,
·3· · came from, from those decisions as to those
·4· · factors.
·5· · · · ·Q· · ·And you don't cite to any
·6· · economic literature in paragraph 27
·7· · supporting the notion that these factors
·8· · are relevant, is that correct?
·9· · · · ·A· · ·I don't believe in paragraph 27
10· · I do, no.
11· · · · ·Q· · ·Are you aware of the basis on
12· · which the Delaware courts found these
13· · factors to be relevant to their analysis in
14· · Dell, DFC or Aruba?
15· · · · ·A· · ·I'm not sure if I'm aware or
16· · not.· You know, I've read the decisions.  I
17· · don't have an opinion on the basis, so.
18· · · · ·Q· · ·Were these 10 factors the only
19· · factors considered by the courts in
20· · rendering their decisions in Dell, DFC and
21· · Aruba?
22· · · · ·A· · ·Well, the decisions involved, I
23· · think, you know, as per my recollection,
24· · were based on factors not just, you know,
25· · related to market efficiency.· The courts
·1· · · · · · · · · ·A. Shivdasani
·2· · ruled on other aspects of the case as well.
·3· · · · ·Q· · ·All right.
·4· · · · ·A· · ·I'm not saying that those
·5· · courts' decisions were influenced solely by
·6· · these 10 factors, but my reading was that
·7· · these were factors that the courts
·8· · considered.
·9· · · · ·Q· · ·Let's talk a little bit about
10· · the Dell decision.
11· · · · · · · ·Are you aware that the Delaware
12· · Supreme Court in Dell ascribed weight to
13· · the what it described as a lengthy market
14· · check in which alternative buyers for Dell
15· · were canvassed during both the pre-signing
16· · market check and post-signing go-shop?
17· · · · ·A· · ·Are you referring to the Supreme
18· · Court decision that just came out just a
19· · few days ago?
20· · · · ·Q· · ·No, the Supreme Court decision
21· · in Dell.
22· · · · ·A· · ·I may have read it, but it was
23· · not really a focus of my investigation and
24· · I am not offering any opinions on that.
25· · · · ·Q· · ·And are you aware that Michael
·1· · · · · · · · · ·A. Shivdasani
·2· · Dell committed to vote his shares in
·3· · proportion to the number of unaffiliated
·4· · shares that voted in favor of any superior
·5· · proposal that emerged during the go-shop?
·6· · · · ·A· · ·That was not a focus of my
·7· · report.· I don't intend to offer any
·8· · opinions on it.· So it's not a matter I've
·9· · investigated.
10· · · · ·Q· · ·Are you aware that unlike
11· · Mr. Dell, BAT stated at the outset that it
12· · was not interested in selling its shares of
13· · Reynolds' stock under any circumstances?
14· · · · ·A· · ·You know, as I mentioned, this
15· · was not a focus of my investigation.· I am
16· · not offering any opinions on that matter.
17· · · · ·Q· · ·Is it your understanding that
18· · the Dell decision indicates that market
19· · price assuming a semi-strong efficient
20· · market is the best indicator of fair value
21· · for purposes of a judicial appraisal?
22· · · · ·A· · ·Could you repeat that, please?
23· · · · · · · ·MR. SHINDEL:· Sure.· Can you
24· · · · ·read it back?
25· · · · · · · ·(Whereupon, the requested
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·portion was read back by the Court
·3· · · · ·Reporter.)
·4· · · · ·A· · ·Again, it's possible I may have
·5· · read it, but it was not a focus.· I'm not
·6· · offering any opinions on that.· So it's not
·7· · an issue that I've investigated in my
·8· · report.
·9· · · · ·Q· · ·Let's talk about the DCF.
10· · · · · · · ·The Delaware Supreme Court in
11· · DCF did not come to any conclusion about
12· · how to value DFC, correct?
13· · · · ·A· · ·I have no recollection of that.
14· · · · ·Q· · ·The Delaware Supreme Court in
15· · DFC believes that the deal price, not the
16· · market price, should have received heavier
17· · weight than the Court of Chancery gave it
18· · in DFC, right?
19· · · · ·A· · ·As I said, I may have read
20· · newspaper coverage on that.· I haven't read
21· · the opinion and it did not -- yeah, so.
22· · · · ·Q· · ·I'm talking about DFC, not
23· · Aruba.
24· · · · ·A· · ·I'm sorry.
25· · · · ·Q· · ·So you've read the DFC opinion,
·1· · · · · · · · · ·A. Shivdasani
·2· · right?
·3· · · · ·A· · ·I've read it.· That was not the
·4· · focus of my, of my reading.· My focus was
·5· · to look at what factors they considered.
·6· · · · · · · ·And so as part of that, I
·7· · reviewed these legal rulings, but I did not
·8· · really focus on them and they don't form
·9· · the basis of the opinions that I'm
10· · offering.· I did not focus on what they
11· · actually concluded in each matter.  I
12· · focused on the factors that they
13· · considered.
14· · · · ·Q· · ·Did the BAT Reynolds' merger
15· · involve a robust market check, in your
16· · view?
17· · · · ·A· · ·It was not an area investigated.
18· · I don't have any opinion on that.
19· · · · ·Q· · ·Do you know if there was any
20· · market check?
21· · · · ·A· · ·I have not investigated that
22· · issue.
23· · · · ·Q· · ·I didn't ask whether you
24· · investigated it.· I asked whether you're
25· · aware.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·I am not aware that there was a
·3· · market check, but I haven't done an
·4· · analysis of that issue.· So I'm just
·5· · telling you what my awareness is based on,
·6· · on lack of analysis.
·7· · · · ·Q· · ·Are you aware that the Delaware
·8· · Supreme Court in DFC stated that appraisal
·9· · historically has been most useful when
10· · private companies are being acquired or
11· · public companies are subject to a
12· · conflicted buyout?
13· · · · · · · ·THE WITNESS:· Could you repeat
14· · · · ·that, please?
15· · · · · · · ·(Whereupon, the requested
16· · · · ·portion was read back by the Court
17· · · · ·Reporter.)
18· · · · ·A· · ·It's possible I may have read
19· · that.· I don't know.· Again, it did not
20· · form the basis for any of the opinions I'm
21· · offering in this matter.
22· · · · ·Q· · ·The BAT Reynolds merger did not
23· · involve the sale of Reynolds to some
24· · outside third party, right?
25· · · · ·A· · ·Again, I have no opinions on
·1· · · · · · · · · ·A. Shivdasani
·2· · that.· I don't know how you define third
·3· · party.· That was not a focus of my
·4· · analysis.
·5· · · · ·Q· · ·Reynolds was acquired by its 42
·6· · percent stockholder BAT, right?
·7· · · · ·A· · ·That is correct.
·8· · · · ·Q· · ·And before the acquisition, BAT
·9· · announced it was not a seller under any
10· · circumstances, right?
11· · · · ·A· · ·I believe you represented that
12· · earlier in a question.· Again, it was not a
13· · focus of my analysis.
14· · · · ·Q· · ·BAT announced its merger
15· · proposal on October 20, 2016, correct?
16· · · · ·A· · ·Well, I thought it was on
17· · October 21.
18· · · · ·Q· · ·Well, you may be right.
19· · · · · · · ·In October of 2016, do you know
20· · when the merger closed?
21· · · · ·A· · ·Yes.· I believe I have some
22· · reference in my report, but I would say
23· · approximately 3 months later.
24· · · · ·Q· · ·Since the merger closed 3 months
25· · later?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Oh, sorry -- no, it closed, it
·3· · closed later.· I have a reference on that
·4· · date.· I just don't recall it off the top
·5· · of my head.
·6· · · · ·Q· · ·The merger agreement was
·7· · announced in --
·8· · · · ·A· · ·No, no, you're right, the merger
·9· · did not close 3 months later.· The final
10· · deal value, I believe, was approximately 3
11· · months later.· The merger closed following
12· · that.· I just don't recall the exact date,
13· · but it's in my report.
14· · · · ·Q· · ·Is it fair to say the merger
15· · closed approximately 10 months after the
16· · initial proposal was announced by BAT?
17· · · · ·A· · ·Yes, that sounds about right.
18· · · · ·Q· · ·All right.
19· · · · · · · ·Do you know what the lag time
20· · was between announcement and closing of the
21· · merger in Aruba?
22· · · · ·A· · ·No, I do not.
23· · · · ·Q· · ·I know you haven't read the
24· · Supreme Court opinion in Aruba.· Did the
25· · press reports that you read have any
·1· · · · · · · · · ·A. Shivdasani
·2· · commentary about the relevance that the
·3· · Delaware Supreme Court ascribed to the lag
·4· · time between announcement and closing of
·5· · the merger in Aruba?
·6· · · · · · · ·MS. VALENTE:· Objection.· Are
·7· · · · ·you talking announcement of the offer
·8· · · · ·or announcement of the deal?
·9· · · · · · · ·MR. SHINDEL:· The announcement
10· · · · ·of the offer.
11· · · · ·A· · ·So the article in the Financial
12· · Times that I read I don't recall having a
13· · discussion -- perhaps they did, but I don't
14· · recall that.· So no, I don't have a
15· · recollection or understanding of that.
16· · · · ·Q· · ·Do you agree that if there is
17· · value relevant non-public information, that
18· · such information, by definition, is not
19· · incorporated into the trading price in a
20· · semi-strong efficient market?
21· · · · ·A· · ·Could you repeat that question,
22· · please?
23· · · · · · · ·(Whereupon, the requested
24· · · · ·portion was read back by the Court
25· · · · ·Reporter.)
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Yeah, I would agree with that as
·3· · a general proposition.
·4· · · · ·Q· · ·Did you perform any analysis to
·5· · determine whether there was non-public
·6· · value relevant information with respect to
·7· · RAI at the time of the merger between RAI
·8· · and BAT closed?
·9· · · · ·A· · ·No, I did not.
10· · · · ·Q· · ·All right.
11· · · · · · · ·Let's talk about the 10 factors
12· · that you laid out in your report.
13· · · · · · · ·The first factor you look at is
14· · whether Reynolds is a publicly traded
15· · company, right?
16· · · · ·A· · ·That is correct.
17· · · · ·Q· · ·And your discussion of this
18· · issue is reflected in paragraph 30 of your
19· · report?
20· · · · ·A· · ·That is correct.
21· · · · ·Q· · ·Being publicly traded in and of
22· · itself really says nothing about whether
23· · the market for a given security is
24· · efficient, right?
25· · · · ·A· · ·I would agree with that as a
·1· · · · · · · · · ·A. Shivdasani
·2· · general proposition, the very fact of being
·3· · publicly traded does not imply efficiency.
·4· · · · ·Q· · ·And being publicly traded is
·5· · kind of a minimum condition allowing for
·6· · the potential of an efficient market,
·7· · right?
·8· · · · ·A· · ·I think that's a good way to
·9· · phrase it.
10· · · · ·Q· · ·If a security isn't publicly
11· · traded, it doesn't even have a market in
12· · the sense that the word market is being
13· · used in the efficient capital markets
14· · hypothesis, correct?
15· · · · ·A· · ·Could you repeat that question,
16· · please?
17· · · · ·Q· · ·I'll move on.
18· · · · · · · ·With respect to paragraph 30 and
19· · this issue of being a publicly traded
20· · company, what expertise did you bring to
21· · bear in determining that RAI is a publicly
22· · traded company?
23· · · · ·A· · ·So I think I just want to
24· · clarify.· On paragraph 30, which is on
25· · paragraph 27 factor A, my understanding is
·1· · · · · · · · · ·A. Shivdasani
·2· · it's not just publicly traded.· It's
·3· · publicly traded on a major exchange, which
·4· · I understood to be the NYSE and Nasdaq.
·5· · · · · · · ·So you're correct, it does not
·6· · require any financial expertise to
·7· · determine whether or not a company is on
·8· · the Nasdaq or NYSE.
·9· · · · ·Q· · ·Okay.
10· · · · · · · ·The next factor you looked at
11· · was RAI's market capitalization, right?
12· · · · ·A· · ·That is correct.
13· · · · ·Q· · ·And your analysis on this point
14· · is reflected in paragraphs 31 and 32 of
15· · your report?
16· · · · ·A· · ·That is correct.
17· · · · ·Q· · ·You do not cite any academic
18· · literature suggesting that market
19· · capitalization is relevant to whether a
20· · market is efficient, correct?
21· · · · ·A· · ·I do not cite any literature,
22· · that is correct.
23· · · · ·Q· · ·You only cite to judicial
24· · decisions?
25· · · · ·A· · ·I do, that is correct.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·What expertise did you bring to
·3· · bear in determining RAI's market cap?
·4· · · · ·A· · ·You know, I don't know what you
·5· · mean by expertise in this matter.· I know
·6· · how to calculate market cap, so that's what
·7· · I did.· I compared it to the market cap of
·8· · other companies, such as those in the S&P
·9· · 500, the universe of stocks traded on the
10· · New York Stock Exchange.· Those are the
11· · types of calculations I've done in the
12· · past.
13· · · · · · · ·So I conducted those
14· · calculations in accordance with which I
15· · believe finance professionals would conduct
16· · them.· But, you know, I can't answer what
17· · expertise I brought to it.· I don't know
18· · how to answer that question.
19· · · · ·Q· · ·The calculations involved
20· · arithmetic, right?
21· · · · ·A· · ·No.· Actually, they're
22· · multiplications, yeah -- yeah, that's
23· · right, arithmetic, yeah.
24· · · · ·Q· · ·The next factor you looked at
25· · was RAI's public float, correct?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·That is correct.
·3· · · · ·Q· · ·And your discussion on this
·4· · point appears in paragraphs 33 and 34 of
·5· · your report?
·6· · · · ·A· · ·That is correct.
·7· · · · ·Q· · ·You do not cite any academic
·8· · literature suggesting that public float is
·9· · relevant to whether a market is efficient,
10· · correct?
11· · · · ·A· · ·No, I don't cite any literature
12· · there, no.
13· · · · ·Q· · ·You only cite to judicial
14· · decisions?
15· · · · ·A· · ·I believe so.
16· · · · ·Q· · ·You state in paragraph 34 that
17· · Reynolds' public float was in the range of
18· · 57.6 percent to 57.8 percent of shares
19· · outstanding during the pre-merger period,
20· · correct?
21· · · · ·A· · ·Yes, at the end of each quarter
22· · during that period.
23· · · · ·Q· · ·And the pre-merger period is a
24· · defined term in your report that refers to
25· · the period of time from October 20, 2015
·1· · · · · · · · · ·A. Shivdasani
·2· · through October 20, 2016, correct?
·3· · · · ·A· · ·Yes, that is correct.· It's what
·4· · I call the one-year period prior.· Whether
·5· · the dates you represented are exactly those
·6· · dates or whether they're off by one date, I
·7· · don't know -- but yes, roughly that period.
·8· · · · ·Q· · ·All right.
·9· · · · · · · ·October 2015 is not 19 months
10· · prior to the valuation date that's relevant
11· · in this action, right?
12· · · · ·A· · ·It's possible.· I don't recall
13· · the exact timeframe.
14· · · · ·Q· · ·In footnote 49 of your report
15· · you note that the Court in Dell stated that
16· · Dell's public float was 84.29 percent of
17· · shares outstanding, right?
18· · · · ·A· · ·That is what I state, that is
19· · correct.
20· · · · ·Q· · ·Significantly higher percentage
21· · than RAI's public floats relative to total
22· · shares outstanding, right?
23· · · · ·A· · ·Well, it is a higher percentage,
24· · that is correct.
25· · · · ·Q· · ·Footnote 49 also notes that in
·1· · · · · · · · · ·A. Shivdasani
·2· · Aruba the public float represented 96
·3· · percent of total shares outstanding,
·4· · correct?
·5· · · · ·A· · ·That is correct.
·6· · · · ·Q· · ·Do you know what percentage of
·7· · DFC's shares outstanding were in DFC's
·8· · public float?
·9· · · · ·A· · ·I don't recall the percentage.
10· · I talk about the number of shares in my
11· · footnote.
12· · · · ·Q· · ·Did you look at what percentage
13· · of DFC's shares outstanding were comprised
14· · of the public float?
15· · · · ·A· · ·I don't recall if I looked or
16· · not.· I think what I was doing in this
17· · paragraph was, as I was making the
18· · calculations for Reynolds, I was just
19· · pointing to the numbers that the court
20· · decision cited for those factors in the
21· · rulings that I looked at.· So I don't
22· · recall if I did that calculation or not.
23· · · · ·Q· · ·Are you aware of any judicial
24· · decision in which a court has cited a
25· · public float representing as low a
·1· · · · · · · · · ·A. Shivdasani
·2· · percentage of total shares outstanding as
·3· · RAI's public float as being evidence of a
·4· · semi-strong efficient market?
·5· · · · ·A· · ·Well -- I'm sorry, can you
·6· · repeat that question?
·7· · · · · · · ·(Whereupon, the requested
·8· · · · ·portion was read back by the Court
·9· · · · ·Reporter.)
10· · · · ·A· · ·No, I don't believe I have.  I
11· · think what I was -- what I observed on this
12· · issue is that some court decisions looked
13· · at the percentage of shares outstanding.
14· · In DFC, they looked at the number of shares
15· · outstanding.· I considered both of those
16· · metrics.· I reported both of those metrics
17· · in my report.
18· · · · ·Q· · ·This factor is the public float,
19· · right?
20· · · · ·A· · ·That is correct.
21· · · · ·Q· · ·The total number of shares
22· · outstanding in a corporation has nothing to
23· · do necessarily with the public float,
24· · right?
25· · · · ·A· · ·I misspoke.· I meant the number
·1· · · · · · · · · ·A. Shivdasani
·2· · of shares in the public float not
·3· · outstanding.· That's what I was referring
·4· · to.· Thank you for pointing out my
·5· · misstatement.
·6· · · · ·Q· · ·All right.
·7· · · · · · · ·What expertise did you bring to
·8· · bear in calculating the percentage of RAI's
·9· · shares outstanding that are comprised of
10· · its public float?
11· · · · ·A· · ·I don't know how to answer that
12· · question.· I know how to look at, you
13· · know -- look up the outstanding shares.  I
14· · know how to calculate public float.· So I
15· · just did it in accordance with how these
16· · things are typically done.
17· · · · ·Q· · ·The next factor you looked at
18· · was RAI's average trading volume, right?
19· · · · ·A· · ·That is correct.
20· · · · ·Q· · ·Your discussion of that issue
21· · appears in paragraphs 35 and 36 of your
22· · report?
23· · · · ·A· · ·That is correct.
24· · · · ·Q· · ·You don't cite any academic
25· · literature suggesting that average trading
·1· · · · · · · · · ·A. Shivdasani
·2· · volume is relevant to whether a market is
·3· · efficient, right?
·4· · · · ·A· · ·No, I do not.
·5· · · · ·Q· · ·You only cite to judicial
·6· · decisions?
·7· · · · ·A· · ·That is correct.
·8· · · · ·Q· · ·You calculated that during what
·9· · you define as the pre-merger period -- the
10· · one year prior -- on average 1.7 percent of
11· · Reynolds' outstanding shares were traded
12· · weekly, right?
13· · · · ·A· · ·That is correct.
14· · · · ·Q· · ·You then quote the Dell decision
15· · as citing a source for the proposition that
16· · turnover measured by average weekly trading
17· · of 2 percent or more of the outstanding
18· · shares would justify a strong presumption
19· · that the market is an efficient one, right?
20· · · · ·A· · ·That is correct.
21· · · · ·Q· · ·By that metric, no such
22· · presumption is applicable to Reynolds,
23· · right?
24· · · · ·A· · ·Well, I want to clarify.
25· · · · · · · ·What I have not cited, but if
·1· · · · · · · · · ·A. Shivdasani
·2· · memory serves me correct, there was
·3· · additional context behind that metric.
·4· · · · · · · ·I believe they also made
·5· · reference to a 1 percent average weekly
·6· · trading volume.· In my exhibits, I also
·7· · report that metric as well.· So I did not
·8· · rely exclusively on this 2 percent
·9· · threshold, in my opinions in this case.
10· · · · · · · ·As I talk about in my report,
11· · there's roughly about 25 percent of weeks
12· · that I considered met the 2 percent
13· · threshold.
14· · · · ·Q· · ·Well, I want to get back to
15· · that, but first I want to restate my
16· · question because I don't think you answered
17· · it.
18· · · · ·A· · ·Okay.
19· · · · ·Q· · ·In the last sentence of
20· · paragraph 36 of your report, you write:· "I
21· · understand that in the context of Dell, the
22· · Delaware Supreme Court cited a source
23· · stating that turnover measured by average
24· · weekly trading of 2 percent or more of the
25· · outstanding shares would justify a strong
·1· · · · · · · · · ·A. Shivdasani
·2· · presumption that the market for the
·3· · security is an efficient one," correct?
·4· · · · ·A· · ·That is correct.
·5· · · · ·Q· · ·Based on that metric that's
·6· · actually quoted in your report, Reynolds
·7· · should not have that presumption because
·8· · Reynolds' -- less than 2 percent of
·9· · Reynolds' shares on an average weekly basis
10· · were traded, right?
11· · · · ·A· · ·I think if you look at the
12· · entire timeframe of the pre-merger period,
13· · as I note in my report the average trading
14· · volume was 1.7 percent of shares
15· · outstanding.· And if you look week by week,
16· · roughly 25 percent of the weeks during that
17· · period had average trading volume of 25
18· · percent or more.
19· · · · ·Q· · ·So --
20· · · · ·A· · ·I would say 25 percent, roughly
21· · 25 percent of the weeks, that metric that's
22· · cited was met by Reynolds' stock.
23· · · · · · · ·And if I could just clarify the
24· · number.· It's in my exhibit.
25· · · · ·Q· · ·Exhibit 3A?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Exhibit 3A, yes.
·3· · · · · · · ·I've been saying 25 percent.· As
·4· · I mention in my report, it's 23.5 percent.
·5· · · · ·Q· · ·When you're referring here on
·6· · Exhibit 3A there is a box at the top, the
·7· · top left titled RAI weekly trading volume?
·8· · · · ·A· · ·That is correct.
·9· · · · ·Q· · ·And in 23.5 percent of the weeks
10· · that you look at, the volume exceeded 2
11· · percent?
12· · · · ·A· · ·That is correct.
13· · · · ·Q· · ·And that's what you're referring
14· · to?
15· · · · ·A· · ·That's correct.
16· · · · ·Q· · ·And 76 and a half percent of the
17· · weeks, the volume was less than 2 percent?
18· · · · ·A· · ·That is correct.
19· · · · ·Q· · ·A couple of answers ago you
20· · referred to -- you had a recollection that
21· · Dell, in addition to this part that you
22· · quoted in your report, has other references
23· · to potentially trading at above 1 percent.
24· · · · · · · ·Am I recalling that answer
25· · correctly?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Yeah.· I think what I was
·3· · referring to is the source that I believe
·4· · is cited in the Dell case also had a 1
·5· · percent threshold.· That's my recollection.
·6· · · · ·Q· · ·All right.
·7· · · · · · · ·Well, in reviewing your report
·8· · and trying to consider the opinions that
·9· · you're offering, should I not rely on
10· · what's written in your report and -- or
11· · even the sources that are directly cited,
12· · but go hunting through things that those
13· · sources cite to figure out what your
14· · opinions are?· Because I'm just confused.
15· · · · · · · ·The 1 percent notion doesn't
16· · appear anywhere in your report, right?
17· · · · ·A· · ·Right.· Yeah, I don't know if it
18· · appears.· I don't know if it appears in my
19· · report.
20· · · · · · · ·You are correct, I only cite the
21· · 2 percent number here and I'm not drawing
22· · an inference on average trading volume
23· · solely from this source that the Delaware
24· · Supreme Court cites.· That is provided just
25· · to provide a benchmark comparison as to
·1· · · · · · · · · ·A. Shivdasani
·2· · what courts have stated, so to provide
·3· · context behind these numbers
·4· · · · · · · ·so I did not go and -- my
·5· · approach was not to make these calculations
·6· · and check the box mechanically on every, on
·7· · every factor.
·8· · · · · · · ·So I considered these factors
·9· · and I'm citing this as what a relevant, the
10· · relevant context was in the Dell decision.
11· · · · ·Q· · ·I mean with respect to the
12· · average trading volume of Reynolds, based
13· · on what's in the Dell decision that is
14· · quoted here, the average trading volume of
15· · Reynolds that you calculated of 1.7
16· · percent, you know, which is the average
17· · over the one-year period, right --
18· · · · ·A· · ·Correct.
19· · · · ·Q· · ·-- does not support a
20· · presumption that the market is efficient,
21· · right?
22· · · · ·A· · ·I would say -- I would phrase it
23· · slightly differently.· I think the way it
24· · was phrased in the Dell decision is it
25· · would not justify a strong presumption that
·1· · · · · · · · · ·A. Shivdasani
·2· · the market was an efficient one.
·3· · · · ·Q· · ·And the next factor you looked
·4· · at was Reynolds' bid ask spreads, correct?
·5· · · · ·A· · ·That is correct.
·6· · · · ·Q· · ·Your analysis on that topic
·7· · appears in paragraphs 37 and 38 of your
·8· · report?
·9· · · · ·A· · ·That is correct.
10· · · · ·Q· · ·You state that prices of stocks
11· · with a relatively high bid ask spread have
12· · been found to incorporate information with
13· · delay, citing to an article from the
14· · Journal of Banking and Finance, right?
15· · · · ·A· · ·That is correct.
16· · · · ·Q· · ·What is a relatively high bid
17· · ask spread in the context of the article
18· · you cite?
19· · · · ·A· · ·I don't have it off the top of
20· · my head.· It's been some time when I
21· · reviewed that article.· But typically the
22· · academic literature defines a high bid ask
23· · spread on a relative basis, relative to
24· · other companies.· So it's not an absolute
25· · number or a dollar or cents amount.· So
·1· · · · · · · · · ·A. Shivdasani
·2· · it's on a relative basis.
·3· · · · · · · ·And in this context, I just
·4· · don't recall the specifics of the study,
·5· · but I'm happy to look at it if you would
·6· · like me to.
·7· · · · ·Q· · ·When you say relative to other
·8· · companies, is it relative to peer
·9· · companies, relevant to the entire market,
10· · relevant to the particular exchange that it
11· · trades on?
12· · · · ·A· · ·As I said, I don't -- now
13· · sitting here, since it's been a while --
14· · recall the specifics of that study.
15· · · · · · · ·But this is something that has
16· · been documented by multiple studies and
17· · they will typically look at a large set of
18· · companies, usually across multiple
19· · exchanges and the approach is to perform
20· · portfolios of companies based upon various
21· · metrics.· And the literature, I think, has
22· · emphasized typically the relative bid ask
23· · spread in that context.
24· · · · · · · ·MR. SHINDEL:· Why don't we take
25· · · · ·a 5-minute break, if that's all right
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·with everybody.
·3· · · · · · · ·THE WITNESS:· Sure.
·4· · · · · · · ·MS. VALENTE:· Sure.
·5· · · · · · · ·THE VIDEOGRAPHER:· Off 10:10.
·6· · · · · · · ·(Recess taken 10:10 a.m.)
·7· · · · · · · ·(Resumed 10:20 a.m.)
·8· · · · · · · ·THE VIDEOGRAPHER:· Back on
·9· · · · ·10:20.
10· ·BY MR. SHINDEL:
11· · · · ·Q· · ·Welcome back, Dr. Shivdasani.
12· · · · ·A· · ·Thank you.
13· · · · ·Q· · ·I believe we left off talking
14· · about bid ask spreads.
15· · · · · · · ·If you turn to page 12 of your
16· · report, I believe the next factor you
17· · looked at was the analyst's coverage of
18· · RAI, is that correct?
19· · · · ·A· · ·That is correct.
20· · · · ·Q· · ·Your analysis of that issue
21· · appears in paragraph 39 of your report?
22· · · · ·A· · ·That is correct.
23· · · · ·Q· · ·You do not cite any academic
24· · literature suggesting that the number of
25· · analysts covering a company is relevant to
·1· · · · · · · · · ·A. Shivdasani
·2· · whether a market is efficient, right?
·3· · · · ·A· · ·So I cite the study by Chang, et
·4· · al. in 2006 where it discusses the number
·5· · of analysts they found in their study.  I
·6· · don't recall whether that study talks about
·7· · the impact of efficiency or not.· So I'm
·8· · not sure.
·9· · · · ·Q· · ·The proposition for which it's
10· · cited in paragraph 39 is simply the average
11· · number of analysts covering U.S. companies,
12· · correct?
13· · · · ·A· · ·Right, and that was the context.
14· · I was not looking to cite the academic
15· · literature in this entire section of my
16· · report, which is the court factors.
17· · · · ·Q· · ·And the court you cite for, on
18· · this analyst coverage point is the Delaware
19· · Supreme Court in Dell, correct?
20· · · · ·A· · ·Yes, I believe that is correct.
21· · · · ·Q· · ·I think footnote 61 on the next
22· · page.
23· · · · ·A· · ·You know -- yes, thank you for
24· · pointing that out.
25· · · · · · · ·I also -- you know, I don't
·1· · · · · · · · · ·A. Shivdasani
·2· · recall if Aruba also had that or not, but
·3· · you're correct, I do cite Dell.
·4· · · · ·Q· · ·Fair enough.· You cite to both
·5· · Dell and Aruba, it looks like, in footnote
·6· · 61.
·7· · · · ·A· · ·That is correct.
·8· · · · ·Q· · ·And, coincidentally, both Dell
·9· · and Aruba had 33 research analysts covering
10· · their stock, according to those decisions,
11· · right?
12· · · · ·A· · ·That is my understanding.· Can
13· · you point me to -- yeah.
14· · · · ·Q· · ·In footnote 61, you write, you
15· · understand in the context of Dell, the
16· · Court cited a source noting Dell stock had
17· · 33 research analysts covering it.
18· · · · · · · ·And the final sentence of that
19· · footnote, you write, you further understand
20· · that in the context of Aruba, Aruba had 33
21· · research analysts covering its stock.
22· · · · ·A· · ·Yes, that is correct.· That's
23· · what I cite in my report.
24· · · · ·Q· · ·You identified only 14 analysts
25· · that were covering RAI during the
·1· · · · · · · · · ·A. Shivdasani
·2· · pre-merger period, right?
·3· · · · ·A· · ·Yes.· I discuss 14 analysts in
·4· · my report.
·5· · · · · · · ·The reason I want to be a little
·6· · careful in how I answer this is it's
·7· · possible I identified more, but included
·8· · only 14.
·9· · · · · · · ·I believe as part of the process
10· · of identifying analysts, I also verified
11· · that there were issuing earnings estimates
12· · and so forth.· But I make reference to 14
13· · analysts.· It's possible there had been
14· · more, but I didn't rely on a number
15· · different than 14.
16· · · · ·Q· · ·In footnote 61, you write that
17· · you understand that in the context of DFC,
18· · DFC had 10 analysts covering its stock, and
19· · then you cite to Aruba.
20· · · · · · · ·Do you see that?
21· · · · ·A· · ·Yes, I do.
22· · · · ·Q· · ·Is that a typo?
23· · · · ·A· · ·I don't know if that's a typo or
24· · not.· It's possible the -- I don't know.
25· · It's possible the Aruba decision cited to
·1· · · · · · · · · ·A. Shivdasani
·2· · DFC.· I don't recall at this time.
·3· · · · ·Q· · ·The next factor you look at was
·4· · the number of market makers for Reynolds,
·5· · correct?
·6· · · · ·A· · ·That is correct.
·7· · · · ·Q· · ·Your analysis of that issue
·8· · appears in paragraph 40 of your report?
·9· · · · ·A· · ·That is correct.
10· · · · ·Q· · ·You do not cite any academic
11· · literature suggesting that the number of
12· · market makers for a given company is
13· · relevant to whether a market is efficient,
14· · right?
15· · · · ·A· · ·I don't make -- I don't cite to
16· · that literature, no.
17· · · · ·Q· · ·You only cite to judicial
18· · decisions?
19· · · · ·A· · ·That is correct.
20· · · · ·Q· · ·And, specifically, you cite to
21· · Dell in which there were 145 market makers
22· · for Dell's shares, correct?
23· · · · ·A· · ·That is correct.
24· · · · ·Q· · ·Are you aware of any other
25· · judicial decisions that have addressed the
·1· · · · · · · · · ·A. Shivdasani
·2· · question of whether the number of market
·3· · makers is relevant to the determination of
·4· · whether a market is efficient?
·5· · · · ·A· · ·It's possible that this is a
·6· · factor also considered in the Cammer, as
·7· · part of the Cammer factors and maybe
·8· · Krogman decision as well.· I don't recall
·9· · off the top of my head.· I have seen this
10· · factor prior to this case, but I don't
11· · recall specific rulings.
12· · · · ·Q· · ·Well, you read the Krogman
13· · decision, right?
14· · · · ·A· · ·Yes, I did.
15· · · · ·Q· · ·And you rely on it here --
16· · actually, if you look in footnote 66 at the
17· · bottom of the page, that's in relation to
18· · the factor of public filings.
19· · · · ·A· · ·Correct.
20· · · · ·Q· · ·But you cite Krogman talking
21· · about S3 registration statements and their
22· · significance, right?
23· · · · ·A· · ·That is correct.
24· · · · ·Q· · ·So you relied on Krogman in
25· · drafting your report, right?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Right.· I make citation to
·3· · Krogman.· Like I said, I considered
·4· · Krogman, I would say.
·5· · · · · · · ·MR. SHINDEL:· Mark that one as
·6· · · · ·1302.
·7· · · · · · · ·(Whereupon, Exhibit 1302,
·8· · · · ·Krogman Decision, was marked for
·9· · · · ·Identification, as of this date.)
10· ·BY MR. SHINDEL:
11· · · · ·Q· · ·Dr. Shivdasani, you've been
12· · handed a copy of the Krogman decision, 202
13· · FRD 467 from 2001.
14· · · · · · · ·If you go ahead and turn to page
15· · 9 of the printout, you'll see in the bottom
16· · right-hand corner is page numbers.
17· · · · ·A· · ·Yes.
18· · · · ·Q· · ·And you see there's a little
19· · asterisk 476, the internal page number, and
20· · then Romanette 3, number of market makers.
21· · · · · · · ·Do you see that?
22· · · · ·A· · ·Yes.
23· · · · ·Q· · ·There, the Krogman Court
24· · references the Cammer decision that you've
25· · mentioned and talks about Cammer -- that in
·1· · · · · · · · · ·A. Shivdasani
·2· · Cammer that Court held that the existence
·3· · of numerous market makers might support an
·4· · inference that a company's stock traded in
·5· · an efficient market, right?
·6· · · · ·A· · ·That is correct.
·7· · · · ·Q· · ·Then it goes on to note that in
·8· · contrast, in the O'Neill v. Appel decision,
·9· · the Court held that the existence of a
10· · large number of market makers without more
11· · is virtually meaningless in establishing
12· · whether that market is efficient, correct?
13· · · · ·A· · ·I see that.
14· · · · ·Q· · ·And if you -- and the Court here
15· · in Krogman goes on, and it looks like in
16· · O'Neill there's actually academic
17· · literature discussed and cited for the
18· · proposition that number of market makers is
19· · totally irrelevant to market efficiency,
20· · right?
21· · · · ·A· · ·I see that.· I see that
22· · reference, yes.
23· · · · ·Q· · ·And if you turn to page 10, if
24· · you look right after footnote 12, the
25· · Court's conclusion in Krogman is that the
·1· · · · · · · · · ·A. Shivdasani
·2· · mere presence of market makers does not
·3· · indicate market efficiency, right?
·4· · · · ·A· · ·That is correct.
·5· · · · ·Q· · ·So why do you not cite Krogman
·6· · for this point in your section discussing
·7· · market makers?
·8· · · · ·A· · ·You know, this section is --
·9· · this entire section is all of the factors
10· · that I was aware of at some point in time,
11· · that courts have considered at some point
12· · in time in their assessment of market
13· · efficiency, and I am providing what
14· · specific benchmarks were for some of those
15· · factors largely in these Delaware rulings.
16· · · · · · · ·So I wasn't seeking to do a
17· · comprehensive analysis of all court
18· · decisions and what they found and which --
19· · for each one of these factors.· So that was
20· · not the goal of the citations here.
21· · · · · · · ·The goal of these citations was
22· · to provide the reader with some context
23· · behind what these numbers that I'm
24· · presenting look like for some other court
25· · decisions and to consider all of the
·1· · · · · · · · · ·A. Shivdasani
·2· · factors that the courts have looked at.
·3· · · · · · · ·So in that construct, I didn't
·4· · see a reason to include every court ruling
·5· · that has considered these factors.
·6· · · · ·Q· · ·In your prior answer you
·7· · referred to not conducting a comprehensive
·8· · review and concluded by saying you didn't
·9· · see the need to include every court ruling.
10· · · · · · · ·But you did include Krogman,
11· · right?
12· · · · ·A· · ·Right.
13· · · · ·Q· · ·So you read it?
14· · · · ·A· · ·Yeah.
15· · · · ·Q· · ·You had Krogman?
16· · · · ·A· · ·Right.
17· · · · ·Q· · ·And you included it when it
18· · supported the notion that a particular
19· · factor is relevant to market efficiency,
20· · but you omitted it when Krogman reached the
21· · opposite conclusion.· And my question is,
22· · why did you do that?
23· · · · ·A· · ·Well, I don't recall the
24· · specific reason why, in 41, I cite to
25· · Krogman and not the Dell decisions.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·It's quite possible that factor
·3· · H, which is in paragraph 41, may not have
·4· · been part of some of the Dell decisions
·5· · and, therefore, my understanding of the
·6· · source of this factor or when a court
·7· · considers may have been from the Krogman
·8· · decision.· I was not seeking to omit
·9· · anything deliberately in any of these
10· · references.
11· · · · · · · ·The goal of most of these were
12· · to provide context for the interpretation
13· · of my numbers and a benchmark.
14· · · · ·Q· · ·All right.
15· · · · · · · ·Is the goal of this portion of
16· · your report discussing these various
17· · factors not to suggest that these factors
18· · are relevant to market efficiency?
19· · · · ·A· · ·As I mentioned before, I think
20· · these are -- these were -- I was asked to
21· · consider all the factors that the courts
22· · have considered as being relevant to their
23· · assessment of market efficiency.· That's
24· · the goal of this section.
25· · · · · · · ·As I mentioned before, these
·1· · · · · · · · · ·A. Shivdasani
·2· · factors have varying degrees of relevance
·3· · in my opinion from a financial economist's
·4· · perspective.
·5· · · · · · · ·But I did not take any position
·6· · in my report about the relevance.· I just
·7· · considered all the factors.· I was asked to
·8· · consider any other factors I thought would
·9· · be relevant to this assessment, which I
10· · also did.
11· · · · · · · ·Here, I am just going through
12· · the list of factors that the courts have
13· · considered and providing the numbers and
14· · the assessment for those factors for
15· · Reynolds.
16· · · · ·Q· · ·So I just want to make sure that
17· · I understand what you did and what you
18· · didn't do.
19· · · · ·A· · ·Right.
20· · · · ·Q· · ·So these 10 factors that we're
21· · in the middle of going through, towards the
22· · end of going through, I suppose, are a
23· · mixture of factors provided to you by
24· · counsel, although you don't recall getting
25· · a specific list, look at these -- you know,
·1· · · · · · · · · ·A. Shivdasani
·2· · counsel provided you with factors, pointed
·3· · you towards certain judicial decisions,
·4· · specifically the Delaware decision, Dell,
·5· · DFC and Aruba, and you personally were
·6· · aware of Cammer and Krogman.
·7· · · · ·A· · ·Uh-huh.
·8· · · · ·Q· · ·And so these factors are a
·9· · mixture of what counsel discussed with you
10· · and what you came up with by reading
11· · through these decisions.
12· · · · · · · ·Is that an accurate summary of
13· · how you arrived at these 10 factors?
14· · · · ·A· · ·I would say it's fairly
15· · accurate, except I think part of your
16· · question was counsel discussed these
17· · factors.· I don't actually recall a
18· · discussion of specific factors.
19· · · · ·Q· · ·Okay.
20· · · · ·A· · ·They pointed me to the rulings
21· · and I was aware of some these factors.
22· · · · · · · ·So when I was asked to conduct
23· · an analysis of all the factors courts have
24· · considered, I did request from counsel the
25· · relevant rulings in their mind to make sure
·1· · · · · · · · · ·A. Shivdasani
·2· · that I was not overlooking something
·3· · meaningful by the courts.
·4· · · · ·Q· · ·But you're not taking a position
·5· · about the relative importance of any of
·6· · these 10 factors or even whether certain of
·7· · these factors like market makers are at all
·8· · relevant to whether a market is efficient?
·9· · · · ·A· · ·No, I am not taking a position
10· · in this -- I have not taken a position and
11· · I'm not offering that position.
12· · · · · · · ·But I think as Wells Fargo'
13· · already talked about, there is a factor in
14· · here among these 10 that is a very
15· · widely-used factor in the financial
16· · economics literature and the literature
17· · argued is the appropriate way to examine
18· · market efficiency.
19· · · · · · · ·So there is a factor in here
20· · that I believe has substantial empirical
21· · support that was also important in me
22· · arriving at my conclusions.
23· · · · ·Q· · ·All right.
24· · · · · · · ·Moving on from market makers,
25· · the next factor you looked at was RAI's
·1· · · · · · · · · ·A. Shivdasani
·2· · public filings and eligibility to file an
·3· · S3 registration statement, right?
·4· · · · ·A· · ·Right.
·5· · · · ·Q· · ·Your analysis of that issue
·6· · appears in paragraph 41 of your report?
·7· · · · ·A· · ·Right.
·8· · · · ·Q· · ·And you don't cite any academic
·9· · literature suggesting that eligibility to
10· · file an S3 is relevant to whether a market
11· · is efficient, correct?
12· · · · ·A· · ·That is correct.
13· · · · ·Q· · ·You only cite to judicial
14· · decisions?
15· · · · ·A· · ·That is correct.
16· · · · ·Q· · ·Specifically, you cite to the
17· · Chancery decision in Aruba and to the
18· · Krogman decision that we were just
19· · discussing, right?
20· · · · ·A· · ·That is correct.
21· · · · ·Q· · ·Now, the Chancery decision in
22· · Aruba, aside from the fact that it's now
23· · been reversed, did not place any particular
24· · significance on the ability to file a Form
25· · S3, right?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·I don't have a recollection of
·3· · that.
·4· · · · ·Q· · ·In the Krogman decision and the
·5· · so-called Cammer factors that have come up
·6· · a couple of times today related to whether
·7· · a plaintiff in a securities fraud suit can
·8· · invoke the fraud on the market theory,
·9· · right?
10· · · · ·A· · ·That's possible, that sounds
11· · right, but I don't recall for sure.
12· · · · ·Q· · ·And Krogman and Cammer did not
13· · arise in the context of appraisal actions,
14· · right?
15· · · · ·A· · ·I don't believe it did.
16· · · · ·Q· · ·And Krogman and Cammer do not
17· · conclude that the existence of an efficient
18· · market means the trading price reflects the
19· · fundamental value of a corporation,
20· · correct?
21· · · · ·A· · ·I don't recall seeing that
22· · conclusion, so.
23· · · · ·Q· · ·I mean to the contrary, the
24· · whole point of Krogman and Cammer and the
25· · fraud on the market theory is that the
·1· · · · · · · · · ·A. Shivdasani
·2· · trading price can be artificially depressed
·3· · when the market does not incorporate
·4· · accurate information, right?
·5· · · · ·A· · ·Would you repeat the question?
·6· · · · ·Q· · ·I'll just ask it again.
·7· · · · · · · ·The whole point of Krogman,
·8· · Cammer and the fraud on the market theory
·9· · is that the trading price can be
10· · artificially depressed when the market does
11· · not incorporate accurate information,
12· · right?
13· · · · ·A· · ·You know, I don't know if this
14· · is a -- calls for a legal assessment.· So I
15· · want to be careful.
16· · · · · · · ·I don't have an understanding of
17· · what the legal sort of framework of these
18· · theories are, but what you're asking me was
19· · not a focus of my analysis.· It sounds
20· · right, but I don't have an opinion on it.
21· · · · ·Q· · ·Have you heard of the fraud on
22· · the market theory?
23· · · · ·A· · ·I have heard that term.
24· · · · ·Q· · ·What is your understanding of
25· · the fraud on the market theory?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·I don't -- I don't have a
·3· · recollection of the understanding.· I know
·4· · it's a term that's used in securities class
·5· · action lawsuits frequently, so.· So I'm not
·6· · offering any opinions on that.
·7· · · · ·Q· · ·Have you ever been retained as
·8· · an expert in connection with a securities
·9· · fraud class action?
10· · · · ·A· · ·Yes, I believe I have.
11· · · · ·Q· · ·Do you ever offer any opinions
12· · about whether fraud on the market occurred?
13· · · · ·A· · ·Again, I've looked at it in all
14· · my opinions from the perspective of a
15· · financial economist.· I know this is a
16· · legal construct, the fraud in the market.
17· · I want to be careful.· I may not understand
18· · the full connotation behind it and all the
19· · implications of that theory.
20· · · · · · · ·So it's not really an area of
21· · expertise, the understanding of what the
22· · fraud in the market does and does not
23· · entail.· So I just want to be careful in
24· · how I am responding to your question.  I
25· · look at things from a financial economist's
·1· · · · · · · · · ·A. Shivdasani
·2· · perspective.
·3· · · · ·Q· · ·Well, not these 10 factors?
·4· · · · ·A· · ·Well, as I said, these are
·5· · factors that the courts have considered.  I
·6· · was asked to evaluate those and I'm
·7· · reporting what RAI's stock looked like with
·8· · respect to these factors.
·9· · · · ·Q· · ·That reporting doesn't involve
10· · any financial economic expertise, in large
11· · part, for most of these factors, right?
12· · · · ·A· · ·Well, I guess some of them
13· · perhaps could.· I think there are methods
14· · to calculate bid ask spreads.· I think
15· · there are conventions around that.  I
16· · believe that does require some degree of
17· · expertise.
18· · · · · · · ·I think -- so, you know, I think
19· · we talked about this earlier, you know,
20· · some of these factors require some
21· · understanding at least of how to make the
22· · relevant calculations.
23· · · · ·Q· · ·The bid ask spreads, I
24· · understand that's fair, you know.
25· · Determining whether it's a publicly traded
·1· · · · · · · · · ·A. Shivdasani
·2· · company, that didn't require any particular
·3· · expertise.
·4· · · · ·A· · ·I think we've already covered
·5· · that.· I agree with that.
·6· · · · ·Q· · ·And, you know, counting up the
·7· · number of market makers, you had to find
·8· · access to the data, but there's no
·9· · particular expertise you're bringing to
10· · bear on that one, right?
11· · · · ·A· · ·You know, I'll let you be the
12· · judge of what expertise.· I mean you need
13· · to know what a market maker is.· You know,
14· · that's a subjective assessment.· I don't
15· · have an opinion on that.
16· · · · ·Q· · ·Well, what financial economic
17· · expertise did you bring to bear with
18· · respect to paragraph 40 of your report?
19· · · · ·A· · ·I think an understanding of a
20· · market maker and what they are and where to
21· · look for the information.
22· · · · · · · ·I mean, I'm not saying this
23· · requires a great deal of financial
24· · expertise, but somebody needs to understand
25· · some basic aspect of finance.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·How about paragraph 39, the
·3· · number of analysts that were covering
·4· · Reynolds?
·5· · · · ·A· · ·Yeah, I believe in this context
·6· · when I talk about the number of sell side
·7· · equity analysts, I believe I actually
·8· · verified that they were issuing earnings
·9· · estimates -- you know, there's a lot of
10· · reports that come out.· Some of them may
11· · not have any sort of meaningful content
12· · information.
13· · · · · · · ·The literature on analysts
14· · emphasizes that the role analysts perform
15· · is the information they communicate with
16· · respect to the earnings, the outlook of the
17· · company.· And so I did perform those kinds
18· · of tests that I think were informed by my
19· · training in finance.
20· · · · ·Q· · ·After public filings, the next
21· · factor you looked at was whether Reynolds
22· · had a controlling stockholder, right?
23· · · · ·A· · ·That is correct.
24· · · · ·Q· · ·Your analysis of that issue
25· · appears in paragraph 42 of your report
·1· · · · · · · · · ·A. Shivdasani
·2· · that?
·3· · · · ·A· · ·That is correct.
·4· · · · ·Q· · ·You do not cite any academic
·5· · literature suggesting that lack of a
·6· · controlling stockholder is relevant to
·7· · market efficiency, correct?
·8· · · · ·A· · ·That is correct.
·9· · · · ·Q· · ·You're not offering an
10· · independent opinion as to whether Reynolds
11· · had a controlling stockholder, right?
12· · · · ·A· · ·No, I am not.
13· · · · ·Q· · ·Counsel told you that it did not
14· · and you accepted that characterization for
15· · purposes of this discussion, correct?
16· · · · ·A· · ·That is correct.· In fact, I
17· · asked counsel as to whether or not Reynolds
18· · met the definition from a legal construct
19· · of a controlling shareholder.
20· · · · ·Q· · ·And what expertise in financial
21· · economics are you bringing to bear in
22· · paragraph 42 of your report?
23· · · · ·A· · ·None that I can think of.
24· · · · ·Q· · ·In fact, basically this
25· · paragraph describes understandings that you
·1· · · · · · · · · ·A. Shivdasani
·2· · obtained from counsel, correct?
·3· · · · ·A· · ·That is correct.
·4· · · · ·Q· · ·The next factor you looked at is
·5· · how Reynolds' stock price reacted to
·6· · unexpected value-relevant information,
·7· · correct?
·8· · · · ·A· · ·That is correct.
·9· · · · ·Q· · ·And your analysis of this issue
10· · appears at paragraphs 43 through 79 of your
11· · report, right?
12· · · · ·A· · ·That is correct.
13· · · · ·Q· · ·And your analysis took the form
14· · of an event study, correct?
15· · · · ·A· · ·That is correct.
16· · · · ·Q· · ·You do not conclude based on
17· · your event study that the market for
18· · Reynolds' stock was semi-strong efficient
19· · in any particular point in time, correct?
20· · · · ·A· · ·I'm not sure it's possible to
21· · draw that conclusion.· So I wanted to be
22· · very precise in what my conclusions were.
23· · · · · · · ·I am here examining the
24· · efficient market hypothesis.· The
25· · appropriate way, scientific way to examine
·1· · · · · · · · · ·A. Shivdasani
·2· · a hypothesis is to look for any evidence
·3· · that would represent a rejection of the
·4· · hypothesis, and that is how I've conducted
·5· · my analysis and offered my opinions.
·6· · · · · · · ·So I would characterize my
·7· · findings as being consistent with trading
·8· · in an efficient market.
·9· · · · · · · ·But a hypothesis is not
10· · something you can affirmatively accept.
11· · You look for evidence of whether or not you
12· · can reject a hypothesis, and that's what
13· · I've done.
14· · · · ·Q· · ·You did not conclude based on
15· · your event study that the market price for
16· · Reynolds' stock at any particular time is
17· · equivalent to fair value for purposes of
18· · this appraisal action, right?
19· · · · · · · ·(Whereupon, the requested
20· · · · ·portion was read back by the Court
21· · · · ·Reporter.)
22· · · · ·A· · ·That was not part of my
23· · assignment and I did not do any of that
24· · assessment.
25· · · · ·Q· · ·And you did not conclude based
·1· · · · · · · · · ·A. Shivdasani
·2· · on your event study that the market price
·3· · of Reynolds' stock at any particular time
·4· · should be given any particular weight in
·5· · determining the fair value of Reynolds in
·6· · this action, right?
·7· · · · ·A· · ·That was not part of my
·8· · assignment.· I did not investigate that
·9· · issue.
10· · · · ·Q· · ·Your event study focuses on
11· · seven events, correct?
12· · · · ·A· · ·That is correct.
13· · · · ·Q· · ·Were those seven events the only
14· · events during the period of time you
15· · examined that qualified for inclusion in
16· · the study?
17· · · · ·A· · ·Those were -- well -- I think,
18· · let me break that question down.· You said
19· · examined to qualify for inclusion.
20· · · · · · · ·These are the only events that I
21· · examine in my report.· I did consider other
22· · events, but did not examine them or assess
23· · them because those events did not occur.
24· · · · · · · ·So -- but yes, these are the
25· · seven events that I considered and
·1· · · · · · · · · ·A. Shivdasani
·2· · examined.
·3· · · · ·Q· · ·And what events did you
·4· · consider, but not examine?
·5· · · · ·A· · ·I considered equity issuance,
·6· · but I understood there were no equity
·7· · issuances that Reynolds conducted during
·8· · this period of time and so there was
·9· · nothing for me to examine, but I did
10· · consider that for possible inclusion in
11· · here.
12· · · · ·Q· · ·Were the seven events that you
13· · examined the only instances during the
14· · relevant period of time as you define it in
15· · which new value-relevant information
16· · regarding RAI became public?
17· · · · ·A· · ·That was not something that I
18· · investigated in my report.· I mean -- that
19· · was -- that's really not a relevant
20· · consideration in how to conduct an event
21· · study.· So I didn't evaluate that.
22· · · · · · · ·I would expect that these would
23· · not be the only events, but I did not --
24· · I'm not offering any opinion on whether
25· · there were other events or not in my
·1· · · · · · · · · ·A. Shivdasani
·2· · report.
·3· · · · ·Q· · ·Let's look at paragraph 46 of
·4· · your report.
·5· · · · ·A· · ·Right.
·6· · · · ·Q· · ·It says there you focus on
·7· · events that academic literature identifies
·8· · as typically being associated with a
·9· · meaningful impact on stock prices, right?
10· · · · ·A· · ·Right.
11· · · · ·Q· · ·And so, specifically, you
12· · considered merger announcements, earnings
13· · surprise, dividend changes and share
14· · buybacks, right?
15· · · · ·A· · ·That is correct.
16· · · · ·Q· · ·And a little bit earlier I
17· · believe you also referenced equity
18· · issuances.
19· · · · ·A· · ·That is correct.
20· · · · ·Q· · ·So is that -- do equity
21· · issuances fall under the same category that
22· · academic literature finds them to be
23· · relevant for event study purposes?
24· · · · · · · ·THE WITNESS:· Could you repeat
25· · · · ·that question, please?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·(Whereupon, the requested
·3· · · · ·portion was read back by the Court
·4· · · · ·Reporter.)
·5· · · · ·A· · ·I would say yes.· In this
·6· · paragraph I'm talking about the events I
·7· · consider in this section that I am going to
·8· · evaluate.· But as part of my broader
·9· · consideration in arriving at these events,
10· · I also thought about equity issuances, and
11· · there is reference in my report to that as
12· · well.
13· · · · ·Q· · ·Did Reynolds conduct any share
14· · buybacks that you evaluated in your event
15· · study?
16· · · · ·A· · ·I believe one of the dates had a
17· · share buyback authorization.
18· · · · ·Q· · ·One of the events identified by
19· · the academic literature, as you reported
20· · it, in paragraph 46 are so-called earnings
21· · surprises, right?
22· · · · ·A· · ·Right.
23· · · · ·Q· · ·And many of the events that you
24· · look at involve earnings announcements,
25· · correct?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·That is correct.· I consider all
·3· · of the earnings announcements during the
·4· · interval that I study, yes.
·5· · · · ·Q· · ·So you defined an earnings
·6· · surprise as the difference between reported
·7· · quarterly earnings and the consensus
·8· · forecast by equity analysts covering
·9· · Reynolds, right?
10· · · · ·A· · ·That is correct.
11· · · · ·Q· · ·Is that the definition you use
12· · to select events for your event study?
13· · · · ·A· · ·No.· I looked at all earnings
14· · announcements.· I had to look at all
15· · earnings announcements to evaluate which
16· · ones of those were an earnings surprise.
17· · So I considered all of the earnings
18· · announcements in my event study.
19· · · · ·Q· · ·All right.
20· · · · · · · ·If you turn to paragraph 58 of
21· · your report on page 18, one of the dates
22· · you selected for your event study was
23· · October 27, 2015, right?
24· · · · ·A· · ·That is correct.
25· · · · ·Q· · ·On that date Reynolds announced
·1· · · · · · · · · ·A. Shivdasani
·2· · earnings in line with consensus estimates,
·3· · right?
·4· · · · ·A· · ·That is correct.
·5· · · · ·Q· · ·So the announcement on October
·6· · 27, 2015 was not an earnings surprise
·7· · within your definition?
·8· · · · ·A· · ·Yes, this would not constitute
·9· · the traditional definition of an earnings
10· · surprise and the definition that I use in
11· · my report.
12· · · · ·Q· · ·And there was no merger
13· · announcement on October 27, 2015, right?
14· · · · ·A· · ·I don't believe there was, no.
15· · · · ·Q· · ·And there wasn't a dividend
16· · change one way or other, right?
17· · · · ·A· · ·I don't think there was a
18· · dividend change on this date, no.
19· · · · ·Q· · ·And nor was there a share
20· · buyback?
21· · · · ·A· · ·No.
22· · · · ·Q· · ·Nor was there an equity
23· · issuance?
24· · · · ·A· · ·No.
25· · · · ·Q· · ·Now, the return for Reynolds'
·1· · · · · · · · · ·A. Shivdasani
·2· · stock on October 27, 2015 was negative and
·3· · statistically different from zero according
·4· · to your analysis, correct?
·5· · · · ·A· · ·That is correct.
·6· · · · ·Q· · ·Now, that is not what one would
·7· · expect given a neutral earnings
·8· · announcement, correct?
·9· · · · ·A· · ·Yes, according to the
10· · traditional academic literature, because I
11· · think on average the literature one looks
12· · at lots of different announcements.· On
13· · average you find that when there is no
14· · earnings, a price you wouldn't expect a
15· · significant market reaction.
16· · · · · · · ·Here, I'll look at one specific
17· · company and even there was not an earnings
18· · surprise there was information that was
19· · conveyed to the market, as I talk about in
20· · my report, and I see the stock reacting.
21· · · · · · · ·But you're right, this event
22· · does not constitute an earnings surprise as
23· · it's defined.
24· · · · · · · ·But an earnings announcement,
25· · when it occurs, can raise more than just
·1· · · · · · · · · ·A. Shivdasani
·2· · information about the earnings number.
·3· · There's other issues that are discussed
·4· · during earnings announcements, earnings
·5· · calls, and that's what I'm talking about in
·6· · my report.
·7· · · · ·Q· · ·You talked earlier about, you
·8· · know, the nature of the efficient market
·9· · hypothesis as a hypothesis and the
10· · scientific methods suggest you look at
11· · whether you can, you know, reject the
12· · hypothesis and that's what you're looking
13· · at?
14· · · · ·A· · ·That is correct.
15· · · · ·Q· · ·So -- and under the definition
16· · that you use for earnings surprise, the
17· · announcement on October 27, 2015 is not an
18· · earnings surprise, right?
19· · · · ·A· · ·That is correct.
20· · · · ·Q· · ·And under the academic
21· · literature regarding event studies with
22· · the, you know, expectation is for a
23· · non-surprise and lacking any other
24· · significant event on that date, you would
25· · not expect a return either positive or
·1· · · · · · · · · ·A. Shivdasani
·2· · negative that is statistically different
·3· · from zero, right?
·4· · · · ·A· · ·That is correct.
·5· · · · ·Q· · ·So this data point, given those
·6· · parameters, is evidence that you should, in
·7· · fact, reject the hypothesis?
·8· · · · ·A· · ·No.· The way I would phrase it
·9· · is, you know, the academic literature
10· · would, takes, you know, may suggest that
11· · because this is not an earnings surprise,
12· · this is not a value-relevant information
13· · event and by that metric, you know, some
14· · could take the view that perhaps I
15· · shouldn't have considered this event.
16· · · · · · · ·I didn't want to sort of -- I
17· · wanted to be comprehensive in my analysis.
18· · I was looking at all of the earnings
19· · events.
20· · · · · · · ·The literature talks about
21· · earnings surprises because earnings
22· · surprises we know clearly contain
23· · information events.· But anybody who has
24· · read earnings announcements also knows that
25· · there is other information conveyed.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·So I did not want to -- I wanted
·3· · to be as comprehensive as possible in my
·4· · analysis with respect to earnings events,
·5· · which is why I included it.
·6· · · · · · · ·When I read the actual
·7· · announcement, while there is no earnings
·8· · surprise, there is a lot of other
·9· · information and questions raised by
10· · analysts about the business outlook of the
11· · company.
12· · · · · · · ·When I considered all of that
13· · information, the market reaction on that
14· · date is, in my view, consistent with all of
15· · the information.
16· · · · · · · ·I'm not saying in my report that
17· · the earnings surprise is the only
18· · information that is contained on an
19· · earnings date.
20· · · · ·Q· · ·All right.
21· · · · · · · ·And the information that you
22· · looked at consists of questions that were
23· · asked by particular analysts during the
24· · earnings announcement call following the
25· · earnings announcement on October 27, 2015,
·1· · · · · · · · · ·A. Shivdasani
·2· · right?
·3· · · · ·A· · ·That is correct.
·4· · · · ·Q· · ·And you don't report what the
·5· · answers to the questions were, correct?
·6· · · · ·A· · ·No, I don't.
·7· · · · ·Q· · ·I mean, were the answers to the
·8· · questions not value-relevant information?
·9· · · · ·A· · ·No, I believe they are.
10· · · · ·Q· · ·So how can I tell looking at
11· · what's in your report -- some analysts ask
12· · some questions, the questions had a
13· · negative tone?· You don't say what the
14· · answers to the questions were, but you say
15· · analysts had questions, questions were
16· · negative, that's consistent with a negative
17· · return.· Can you bridge that gap for me?
18· · · · ·A· · ·Right.
19· · · · · · · ·Well, when I looked at the
20· · earnings calls and I looked at the nature
21· · of the questions that were asked, there was
22· · a lot of concern reflected in the questions
23· · about the business outlook of the company,
24· · specifically with respect to specific
25· · products, a lot of questions around certain
·1· · · · · · · · · ·A. Shivdasani
·2· · FDA rulings that were adverse and how that
·3· · may impact certain products that Reynolds
·4· · had, and that's what's reflected in my
·5· · report.
·6· · · · · · · ·I did not seek to make an
·7· · assessment of the answers, how valid those
·8· · answers are, to what extent those answers
·9· · should cause a revision in people's
10· · outlooks.· But I did observe a lot of
11· · concern on items that related to the
12· · business outlook of the company and that's
13· · what I note.
14· · · · · · · ·And the market reaction, in my
15· · view, is consistent with those concerns
16· · being important.· That was clearly evident
17· · in the earnings call.
18· · · · ·Q· · ·All right.
19· · · · · · · ·You did not discuss the contents
20· · of the follow-on earnings call for any of
21· · the other five earnings announcements that
22· · you include in your event study, correct?
23· · · · ·A· · ·No, I do not discuss them in my
24· · report, no.
25· · · · ·Q· · ·Did you review those earnings
·1· · · · · · · · · ·A. Shivdasani
·2· · calls?
·3· · · · ·A· · ·Yes, I did.· I reviewed all of
·4· · the earnings calls.
·5· · · · ·Q· · ·And why are they not noted in
·6· · your report?
·7· · · · ·A· · ·When I -- well, I do cite them
·8· · in my documents considered list.· So they
·9· · are noted.· I don't reference them
10· · specifically in these, on these separate
11· · dates, because I did not see anything
12· · incremental in those earnings calls and
13· · those questions that was, that warranted
14· · any addition to what I was talking about.
15· · · · · · · ·So the kinds of concerns that
16· · were raised on those earnings calls, on
17· · this, on this earnings call on October
18· · 27th, I did not see those types of issues
19· · raised in the earnings.· So there was
20· · nothing for me to add.· It wasn't that I
21· · only reviewed one.
22· · · · ·Q· · ·All right.
23· · · · · · · ·In you look at paragraph 62 of
24· · your report on page 19.
25· · · · ·A· · ·Yes.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·Here you discuss the event, the
·3· · events of February 11, 2016, correct?
·4· · · · ·A· · ·That is correct.
·5· · · · ·Q· · ·And, in particular, there was a
·6· · negative earnings surprise within your
·7· · definition of earnings surprise, right?
·8· · · · ·A· · ·Right.
·9· · · · ·Q· · ·As well as a positive dividend
10· · increase, correct?
11· · · · ·A· · ·That is correct.
12· · · · ·Q· · ·Now, a priori, how would you
13· · expect the market to react to that mixed
14· · news?
15· · · · ·A· · ·It's -- without looking at any
16· · other context, it would be difficult to
17· · ascribe whether the market would -- to
18· · determine.
19· · · · ·Q· · ·Difficult or impossible?
20· · · · ·A· · ·Well, in this context, with
21· · these numbers -- yeah, it would certainly
22· · be difficult.· I'd have to think about
23· · whether it would be impossible or not.· But
24· · it certainly would be difficult.· It may be
25· · impossible.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·There is no principal basis to
·3· · decide on the basis of a 4 percent earnings
·4· · miss and a 16.7 percent dividend increase
·5· · to know how the market is going to react,
·6· · is there?
·7· · · · ·A· · ·In the absence of any other
·8· · information, I would agree with that.
·9· · · · ·Q· · ·What did you do, if anything, to
10· · disambiguate the effect of the negative
11· · earnings surprise from the positive
12· · dividend announcement?
13· · · · ·A· · ·So what I did, as I explain in
14· · my report, I read all the analyst's
15· · commentary on the earnings calls, I read
16· · how analysts were looking at this, the
17· · reasons they were citing, their weighting
18· · of these two factors and I considered that
19· · evidence in disentangling whether this was
20· · a positive, negative, or negative piece of
21· · news to the market.
22· · · · ·Q· · ·All right.
23· · · · · · · ·And in the following paragraph
24· · 63, 64 and -- well, 63 and 64 you discuss
25· · analyst's commentary about the earnings
·1· · · · · · · · · ·A. Shivdasani
·2· · announcement and the dividend increase,
·3· · right?
·4· · · · ·A· · ·That is correct.
·5· · · · ·Q· · ·And you cite to analysts who
·6· · were generally positive on Reynolds'
·7· · despite the earnings miss, right?
·8· · · · ·A· · ·Yeah, I mean -- yes, that's what
·9· · I do.· I cite the factors and the reasoning
10· · behind why the analysts seemed to place
11· · more weight on the dividend increase and
12· · less weight on the earnings miss.
13· · · · · · · ·I mean some of the analysts were
14· · actually raising their price targets and
15· · their ratings on the stock.
16· · · · ·Q· · ·All right.
17· · · · · · · ·It looks like you cite four
18· · different analysts in this section.
19· · · · ·A· · ·That's possible.· I'd have to
20· · count that, but that's possible.
21· · · · ·Q· · ·I believe earlier we talked
22· · about the number of analysts covering
23· · Reynolds and there were 14.
24· · · · ·A· · ·Right.
25· · · · ·Q· · ·Were the other 10 analysts
·1· · · · · · · · · ·A. Shivdasani
·2· · consistent with what's discussed here in
·3· · paragraphs 63 and 64?
·4· · · · ·A· · ·I would say I noticed a high
·5· · degree of consistency.· I read all the
·6· · analysts.· I don't recall every single
·7· · analyst report at this point, but I did
·8· · review all of them and when I looked at the
·9· · collective evidence, it seemed that the
10· · overall assessment of this event was
11· · weighted much more positively towards the
12· · dividend increase than the earnings miss.
13· · · · ·Q· · ·All right.
14· · · · · · · ·So some -- do you recall if
15· · there were any analysts that had a negative
16· · view that took the announcement, the
17· · earnings announcement, the dividend
18· · increase and came out on the bearish side?
19· · · · ·A· · ·I don't recall off the top of my
20· · head.· I recall reading all of these
21· · reports, but I don't recall.
22· · · · ·Q· · ·And what is the relevance of the
23· · analyst commentary?· Is the theory that the
24· · analysts are a proxy for the market at
25· · large or is it that the market is going to
·1· · · · · · · · · ·A. Shivdasani
·2· · follow the analyst's consensus?
·3· · · · ·A· · ·You know, as a general
·4· · proposition, I think the finance literature
·5· · emphasizes that analyst's recommendations,
·6· · communicate information, value relevant
·7· · information to markets.
·8· · · · · · · ·There's somewhat of a debate
·9· · around how much information and when that
10· · information becomes relevant.
11· · · · · · · ·I think my objective in looking
12· · at here was really trying to disentangle
13· · the positive and negative pieces of news
14· · and to make sure that earnings surprises,
15· · that the academic literature has talked
16· · about in the context of very large samples.
17· · · · · · · ·When I'm looking at an earnings
18· · announcement for a specific company, I'm
19· · considering all of the information that is
20· · released.· So I looked at it as a proxy for
21· · the information that will eventually be
22· · conveyed to the financial markets.
23· · · · · · · ·Whether the analyst's report is
24· · simply a proxy for that information or
25· · whether the analyst's report helps form the
·1· · · · · · · · · ·A. Shivdasani
·2· · information to the market was not an issue
·3· · I really investigated or explicitly relied
·4· · upon.
·5· · · · · · · ·So I hope that answers your
·6· · question.
·7· · · · ·Q· · ·It does.
·8· · · · · · · ·I mean, I think -- you treated
·9· · the analyst's commentary, in some cases
10· · questions, as a proxy for the information.
11· · I believe that was part of your prior
12· · answer.· That's the way you're looking at
13· · analyst reports in this section?
14· · · · ·A· · ·That is correct.· That is
15· · correct.
16· · · · ·Q· · ·If we go to paragraph 66 of your
17· · report on page 21, and here you're
18· · discussing the events of April 26, 2016,
19· · correct?
20· · · · ·A· · ·That is correct.
21· · · · ·Q· · ·And the event here was an
22· · earnings announcement, correct?
23· · · · ·A· · ·That is correct.
24· · · · ·Q· · ·There were no other relevant
25· · events that occurred on this date, right?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·I don't believe so.
·3· · · · ·Q· · ·And like the event on October
·4· · 27, 2015, this was not an earnings
·5· · surprise, right?
·6· · · · ·A· · ·That is correct.
·7· · · · ·Q· · ·And why was this event included
·8· · in your report given that it was not an
·9· · earnings surprise and there was no other,
10· · you know, value relevant event that
11· · occurred on April 26, 2016?
12· · · · ·A· · ·Well, this was included because
13· · it's an event I considered.· I did not know
14· · whether or not this would be an earnings
15· · surprise on the date that, you know,
16· · without looking at the earnings numbers.
17· · So I think that's part of the reason.
18· · · · · · · ·I think, you know, the
19· · literature -- I also -- you know, while my
20· · focus was on earnings surprises, I also
21· · wanted to be cognizant of the fact that the
22· · literature uses earnings surprises as a
23· · proxy for the release of value relevant
24· · financial information occurring on that
25· · date.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·And so I did not want to exclude
·3· · a date related to an earnings event where
·4· · such information was being disclosed.
·5· · · · · · · ·So I would say it was in an
·6· · attempt to be comprehensive in my analysis,
·7· · and when I'm looking at earnings dates and
·8· · I'm looking at earnings surprises, which is
·9· · probably the cleanest proxy for the
10· · earnings information on a date, that I was
11· · also considering the totality of the
12· · evidence that was being released on those
13· · dates.
14· · · · ·Q· · ·Now, your report does not
15· · discuss the transcript of the earnings call
16· · that was held on April 26, 2016, right?
17· · · · ·A· · ·It does not discuss it, but as
18· · I've mentioned, I do -- I did consider it
19· · and I did reference it in my documents
20· · considered list.
21· · · · ·Q· · ·But it's not -- I take it that
22· · there were not questions with negative tone
23· · asked in the April 26, 2016 earnings call?
24· · · · ·A· · ·Certainly not to the degree as
25· · to the previous state that they were
·1· · · · · · · · · ·A. Shivdasani
·2· · talking about.
·3· · · · ·Q· · ·And how would you determine what
·4· · degree would have to be exceeded before
·5· · that would be relevant?
·6· · · · ·A· · ·There isn't a precise
·7· · mathematical threshold that I applied.
·8· · · · · · · ·On the earlier date, I saw a lot
·9· · of questions all related to business
10· · outlook, about products, about pricing
11· · issues, specifically the FDA announcement
12· · with respect to certain products and how
13· · that may impact Reynolds.· There was
14· · discussion about Reynolds voluntarily
15· · taking some of its products out.
16· · · · · · · ·So it was an assessment that I
17· · made based upon the overall volume and the
18· · nature of the questions and the issues that
19· · the questions were getting to.
20· · · · · · · ·Obviously, future growth rates,
21· · outlook for the business are very important
22· · for determining a valuation of a company,
23· · and I thought those questions went to those
24· · types of issues.· So it was a qualitative
25· · assessment.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·If we go to paragraph 70 on page
·3· · 22, there you discuss the events of July
·4· · 26, 2016, correct?
·5· · · · ·A· · ·That is correct.
·6· · · · ·Q· · ·And on that date there was an
·7· · earnings surprise and a dividend increase,
·8· · correct?
·9· · · · ·A· · ·That is correct.
10· · · · ·Q· · ·And the earnings surprise was
11· · negative, right?
12· · · · ·A· · ·That is correct.
13· · · · ·Q· · ·Unfavorable.
14· · · · ·A· · ·That's right.
15· · · · ·Q· · ·The dividend increase is
16· · favorable.
17· · · · ·A· · ·That's correct.
18· · · · ·Q· · ·And again, as you write, due to
19· · the concurrent good and bad news -- and I'm
20· · paraphrasing you -- but, a priori, it's
21· · unclear whether the net effect of this
22· · would be positive or negative, correct?
23· · · · ·A· · ·That is correct.
24· · · · ·Q· · ·So how did you disambiguate the
25· · good news and bad news on this date?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·So again, I went to the
·3· · discussion around -- that was contained in
·4· · the analyst reports.· As I mentioned
·5· · before, I read the earnings call.· I looked
·6· · at sort of how the financial analyst
·7· · community was interpreting this and used
·8· · that as a basis to say on net, what was the
·9· · net sort of assessment of this information.
10· · · · ·Q· · ·And here, again, were you using
11· · the analyst's commentary as a proxy for the
12· · information?
13· · · · ·A· · ·Yes, of how the information was
14· · being interpreted and analyzed by the
15· · market.
16· · · · ·Q· · ·And in paragraph 70, the last
17· · sentence you write that the contemporaneous
18· · analyst's commentary suggests that many
19· · analysts viewed this event as unfavorable
20· · news, right?
21· · · · ·A· · ·That is correct.
22· · · · ·Q· · ·And it looks like you quote four
23· · analysts for that proposition, the first
24· · one being Wells Fargo, right?
25· · · · ·A· · ·That is correct.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·And we can just go through it in
·3· · paragraph 71.
·4· · · · ·A· · ·Yes, sure.
·5· · · · ·Q· · ·What you quote Wells Fargo for
·6· · is that the earnings misdrove the stock
·7· · lower.
·8· · · · ·A· · ·Right.
·9· · · · ·Q· · ·So the effect has happened.
10· · Wells Fargo is reporting it.
11· · · · ·A· · ·Right.
12· · · · ·Q· · ·After the fact.
13· · · · ·A· · ·That is correct.
14· · · · ·Q· · ·So Wells Fargo is not making a
15· · characterization ex-ante?
16· · · · ·A· · ·Correct.
17· · · · ·Q· · ·It's just reporting what the
18· · market did?
19· · · · ·A· · ·Right.
20· · · · ·Q· · ·The same thing for Cowen &
21· · Company, right, they're reacting to what
22· · the market already did?
23· · · · ·A· · ·That is correct.
24· · · · ·Q· · ·Same thing for Bank of America,
25· · they've got a theory about what caused the
·1· · · · · · · · · ·A. Shivdasani
·2· · investor disappointment?
·3· · · · ·A· · ·Right.
·4· · · · ·Q· · ·They're not relaying information
·5· · ex-ante in the absence of already knowing
·6· · how the market reacted.· They're trying to
·7· · interpret why the market did what it did.
·8· · · · ·A· · ·Right.· Well, I mean I
·9· · interpreted this as, you know, they're
10· · communicating how this information was
11· · viewed by investors.
12· · · · · · · ·What they're saying is that, you
13· · know, we believe that it's the earnings
14· · miss -- that was how this announcement was
15· · interpreted.
16· · · · · · · ·They're not saying that the
17· · stock should have traded higher because of
18· · the dividend or share buyback announcement.
19· · · · · · · ·I took this analyst commentary
20· · to imply that, on balance, they're
21· · reporting that the market interpreted this
22· · as negative information.
23· · · · ·Q· · ·I mean isn't that entirely
24· · circular?· You have a mixed bag of news, an
25· · earnings miss, a dividend increase, and I
·1· · · · · · · · · ·A. Shivdasani
·2· · overlooked there's a share buyback program
·3· · that's also announced on this date,
·4· · correct?
·5· · · · ·A· · ·Yes.
·6· · · · ·Q· · ·And the market does what it
·7· · does.· In this case the stock price went
·8· · down by a little over 4 percent, right?
·9· · · · ·A· · ·Right.
10· · · · ·Q· · ·And then analysts see that
11· · market reaction and are writing reports
12· · that attempt to explain why the market did
13· · that in the face of mixed news.
14· · · · ·A· · ·And they're saying it did that
15· · because of the earnings miss.
16· · · · ·Q· · ·But any time you have a mixture
17· · of positive or negative news -- and you say
18· · up here, you've agreed with me twice, when
19· · there's been this mixed bag that it's
20· · difficult, if not impossible, tantamount to
21· · impossible to figure out a priori how the
22· · market is going to react, right?
23· · · · ·A· · ·Right.
24· · · · ·Q· · ·So there's three options; it
25· · goes up by a statistically significant
·1· · · · · · · · · ·A. Shivdasani
·2· · amount, it goes down by a statistically
·3· · significant amount, or it doesn't.
·4· · · · ·A· · ·Right.
·5· · · · ·Q· · ·Right?
·6· · · · · · · ·Analysts offering their opinions
·7· · about why one of those three things
·8· · happened just makes this entire analysis
·9· · for this event entirely circular, doesn't
10· · it?
11· · · · ·A· · ·Well, I mean the way I interpret
12· · this is that the analysts are all pointing
13· · to the earnings miss.· They're not
14· · saying -- you know, they're not saying
15· · things like, well, we're surprised the
16· · stock traded down because there was this
17· · great share buyback program that we think
18· · communicates great information or has a
19· · great positive.
20· · · · · · · ·They're pointing to the fact
21· · that it's the earnings miss that was
22· · important in the investors' minds and
23· · that's -- as I said, I'm trying to use the
24· · analyst's commentary as a proxy for the
25· · information that how, what was conveyed and
·1· · · · · · · · · ·A. Shivdasani
·2· · interpreted by the market.
·3· · · · ·Q· · ·But -- I'm sorry, I didn't mean
·4· · to cut you off.· Go ahead.
·5· · · · ·A· · ·So that's how I interpreted the
·6· · question.
·7· · · · · · · ·I mean, I acknowledged that some
·8· · of these, and I recognized this, that some
·9· · of these analysts' reports are actually
10· · reporting on what happened to the stock.
11· · · · · · · ·But I also took the commentary
12· · to indicate the factors that the investment
13· · community was looking at in deciding on how
14· · to react to the stock and whether or not,
15· · therefore, this is positive or negative
16· · news.
17· · · · ·Q· · ·Well, every one of the four
18· · analysts that you cite in paragraph 71 is
19· · reporting on the change in the stock price
20· · and attributing that to the earnings miss,
21· · right?
22· · · · ·A· · ·That's right.
23· · · · ·Q· · ·Now, the earnings miss was the
24· · only piece of negative news that, at least
25· · that you identified, that occurred on that
·1· · · · · · · · · ·A. Shivdasani
·2· · day, right?
·3· · · · ·A· · ·Right.
·4· · · · ·Q· · ·So having observed what the
·5· · market did, the only thing for the analyst
·6· · to attribute that to is the earnings miss,
·7· · right?
·8· · · · ·A· · ·You know, the analyst reports,
·9· · they often talk about a lot of things.· So
10· · I'm not -- you know, I did not sort of seek
11· · to assess what are the only things they can
12· · attribute to.· There are other events in
13· · other analyst reports that I've seen that
14· · sort of take views that, you know, the
15· · market should have done this, the market
16· · should have done that in different contexts
17· · and in different dates.
18· · · · · · · ·Here in paragraph 71 and the
19· · analyst reports that are reviewed all point
20· · to the earnings miss as the cause, and the
21· · factor that seemed to be most important to
22· · investors, and that's what I was trying to
23· · capture as to -- there was no way, aside
24· · from looking at this, for me to disentangle
25· · whether or not this is positive or negative
·1· · · · · · · · · ·A. Shivdasani
·2· · news.
·3· · · · · · · ·So I'm looking to the nature of
·4· · analyst's commentary as a proxy for how
·5· · this information was interpreted by the
·6· · market.
·7· · · · ·Q· · ·I appreciate that, but what I'm
·8· · getting at is, it's one thing if the
·9· · analyst report is couched in terms of the
10· · analyst's evaluation of the mixture of news
11· · independent from what the market has
12· · already done.
13· · · · ·A· · ·Right.
14· · · · ·Q· · ·You know, here each of these
15· · four analysts knows the market reaction and
16· · is simply attributing that to the negative
17· · piece of news that was announced.
18· · · · ·A· · ·Right.
19· · · · ·Q· · ·And, you know, isn't that just
20· · tautological for the purposes of what
21· · you're trying to look at?
22· · · · ·A· · ·No, but, you know, what none of
23· · the analyst's did -- I mean, is to say that
24· · this reaction doesn't make sense.
25· · · · · · · ·I didn't see any analyst report
·1· · · · · · · · · ·A. Shivdasani
·2· · doing or saying things like, well, if I
·3· · take this share repurchase and the dividend
·4· · and I change a DCF model, you know, I would
·5· · come up with a higher stock price.
·6· · · · · · · ·They're not saying that they
·7· · disagree with this market's assessment,
·8· · that the earnings miss was really bad or
·9· · very negative news.· They're not saying
10· · unlike some of the other events that we've
11· · seen that we're going to now raise our
12· · rating because now the stock a lot cheaper
13· · when it shouldn't have been.
14· · · · · · · ·So it's not just what I'm
15· · citing.· It's also what they're not saying
16· · that's important to sort of give full
17· · construct, sort of full context around the
18· · analyst's commentary.
19· · · · · · · ·And I considered all of that
20· · information.
21· · · · ·Q· · ·All right.
22· · · · · · · ·But so I should go ahead and
23· · read all the analyst reports from July 26,
24· · 2016, not just the ones you've cited.
25· · · · ·A· · ·No, that's what I'm saying.
·1· · · · · · · · · ·A. Shivdasani
·2· · Even these reports that I've cited -- I did
·3· · read all those reports.· I am citing a few
·4· · as an example of the kinds of things
·5· · analysts were saying.
·6· · · · · · · ·And what I'm saying is I
·7· · considered the totality of that evidence in
·8· · concluding that this earnings
·9· · disappointment, the negative information
10· · conveyed there to the market seemed to be
11· · the dominant piece of information of all of
12· · the news that was relayed to the market on
13· · that date.
14· · · · ·Q· · ·If you go to paragraph 73 of
15· · your report on the next page, page 23, here
16· · you discuss the events of October 19, 2016,
17· · correct?
18· · · · ·A· · ·Correct.
19· · · · ·Q· · ·Now, on October 19, 2016, there
20· · was a negative earnings surprise, correct?
21· · · · ·A· · ·That is correct.
22· · · · ·Q· · ·And there's no other news on
23· · that date, at least none reported by you in
24· · paragraph 73 here?
25· · · · ·A· · ·That is direct.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·Nothing else that would qualify
·3· · according to the initial, you know, factors
·4· · that we discussed, a share buyback, a
·5· · dividend increase, a merger announcement,
·6· · right?
·7· · · · ·A· · ·That is correct.
·8· · · · ·Q· · ·You would expect that negative
·9· · earnings surprise coupled with no other
10· · significant news to result in a decrease in
11· · the stock price, right?
12· · · · ·A· · ·With no other significant
13· · information is how I would phrase it, yes.
14· · · · ·Q· · ·Well, there was no statistically
15· · significant change in Reynolds' stock price
16· · on October 19, 2016, right?
17· · · · ·A· · ·That is, I believe, correct,
18· · yes.
19· · · · ·Q· · ·And all else equal, negative
20· · earnings surprise, followed by no material
21· · change in stock price, suggests that the
22· · market is not efficient, correct?
23· · · · ·A· · ·Yes.· If I were -- I'm sorry,
24· · could you please repeat that question?
25· · · · · · · ·(Whereupon, the requested
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·portion was read back by the Court
·3· · · · ·Reporter.)
·4· · · · ·A· · ·If all one looks at is just the
·5· · earnings surprise and not consider any
·6· · other information, the stock price not
·7· · reacting significantly would appear to be
·8· · inconsistent with market efficiency, but I
·9· · would argue that it's important to consider
10· · all of the information, earnings
11· · announcements contain information, not just
12· · earnings for the quarter, they contain
13· · information about projection, business
14· · outlooks.
15· · · · · · · ·I think it's well-established in
16· · finance theory that when you value an
17· · entity or come up -- or think about what
18· · determines stock price, it's not just the
19· · earnings in the next quarter that matter or
20· · the past quarter, it's also the future
21· · outlook, and I believe it's important to
22· · consider all of that.
23· · · · · · · ·But yes, if you limited your
24· · analysis solely to the earnings number that
25· · was reported, then that would be a
·1· · · · · · · · · ·A. Shivdasani
·2· · conclusion that we could draw.· But I don't
·3· · think that would be the right way to do the
·4· · analysis.
·5· · · · · · · ·MR. SHINDEL:· Let's take a
·6· · · · ·break.
·7· · · · · · · ·THE WITNESS:· Okay.
·8· · · · · · · ·THE VIDEOGRAPHER:· Off 11:26.
·9· · · · · · · ·(Recess taken 11:26 a.m.)
10· · · · · · · ·(Resumed 11:40 p.m.
11· · · · · · · ·THE VIDEOGRAPHER:· Back on
12· · · · ·11:40.
13· ·BY MR. SHINDEL:
14· · · · ·Q· · ·Welcome back, Dr. Shivdasani.
15· · · · ·A· · ·Thank you.
16· · · · ·Q· · ·Before the break, we were
17· · discussing the events on October 19, 2016
18· · in your event study.
19· · · · · · · ·As we talked about before the
20· · break, there was a negative earnings
21· · surprise -- I think, in fact, on that date
22· · there is no statistically significant
23· · change in Reynolds' stock price, right?
24· · · · ·A· · ·That is correct, on October
25· · 19th, that is correct.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·And you quote in paragraph 74,
·3· · 75 and 76 some analyst's commentary and
·4· · analyst questions during the earnings call
·5· · that you suggest moderated the impact of
·6· · the negative earnings surprise, right?
·7· · · · ·A· · ·Right.
·8· · · · ·Q· · ·And in paragraph 76, if you look
·9· · at the carryover portion of it on page 24,
10· · you quote a response from Reynolds'
11· · management to a question from an analyst
12· · from Stifel during the earnings call,
13· · right?
14· · · · ·A· · ·Right.
15· · · · ·Q· · ·And I'm just wondering, you
16· · know, previously you referenced analyst's
17· · questions with a negative tone in a prior
18· · earnings call, but you didn't quote what
19· · management had to say.
20· · · · ·A· · ·Right.
21· · · · ·Q· · ·I'm just wondering why you chose
22· · to quote management here and not in
23· · connection with the former event.
24· · · · ·A· · ·Right.
25· · · · · · · ·And I think in this case, I felt
·1· · · · · · · · · ·A. Shivdasani
·2· · it was relevant to provide context behind
·3· · the earnings miss.
·4· · · · · · · ·When I looked at this date, you
·5· · know, Reynolds' missed its earnings
·6· · estimate, but there was also a lot of
·7· · information as interpreted by the analyst
·8· · that was positive with respect to its
·9· · outlook and the earnings miss was
10· · attributed in the commentary that I saw to
11· · the role of costs and costs being higher.
12· · · · · · · ·And in this specific answer,
13· · when they talk about expenses, they're
14· · really talking about non-operating
15· · expenses, which are often less permanent in
16· · nature.
17· · · · · · · ·So it was just to provide
18· · context that I felt was relevant in this
19· · case on this event about the reason for the
20· · earnings missed.
21· · · · · · · ·This was different than a
22· · disappointment that might be interpreted as
23· · one that's having a long-ranging impact on
24· · the future business outlook that this
25· · was -- it was really to highlight that it
·1· · · · · · · · · ·A. Shivdasani
·2· · was non-operating expenses that was an
·3· · important part.
·4· · · · · · · ·And so that's what they're --
·5· · that's why.
·6· · · · ·Q· · ·So the management answer that
·7· · you quote here tends to suggest in your
·8· · interpretation that the increased expenses
·9· · that had an effect on earnings in this
10· · particular quarter were not going to
11· · reoccur, is that why you included it?
12· · · · ·A· · ·No.· I think it was -- I
13· · included it just to provide as complete a
14· · representation of the information that is
15· · being conveyed.
16· · · · · · · ·I felt that the reason for the
17· · earnings miss was important and certainly
18· · the market seemed to -- or the analysts
19· · seemed to be focused on the reason for the
20· · earnings miss.
21· · · · · · · ·And so this really speaks to
22· · that.· It's to provide a complete picture
23· · as I felt was important to communicate with
24· · respect to this particular date.
25· · · · ·Q· · ·All right.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·In the next section of your
·3· · report, I believe it's paragraphs 80
·4· · through 92, you discuss the ability to sell
·5· · RAI stock short during both the pre-merger
·6· · period and what you call the extended
·7· · pre-merger period, correct?
·8· · · · ·A· · ·That is correct.
·9· · · · ·Q· · ·Your sole proxy for short
10· · selling constraints was whether RAI
11· · appeared on the New York Stock Exchange
12· · short sale restriction list, correct?
13· · · · ·A· · ·That's not the only factor that
14· · I considered.· Yes, I do look at whether
15· · they appear on that list, but I also looked
16· · at the actual pattern of short selling to
17· · make an assessment of the possible
18· · existence of short selling constraints.
19· · · · ·Q· · ·You look at the pattern of short
20· · selling around the Lorillard deal, right?
21· · · · ·A· · ·That is correct.
22· · · · ·Q· · ·You acknowledge that the
23· · academic literature has analyzed more
24· · nuanced measures of short selling
25· · constraints than appearing on the New York
·1· · · · · · · · · ·A. Shivdasani
·2· · Stock Exchange restricted list, right?
·3· · · · ·A· · ·Yes, I do, and I talk about in
·4· · my report that those analyses are done with
·5· · data that is typically proprietary in
·6· · nature and unavailable to an expert in
·7· · litigation proceedings.
·8· · · · ·Q· · ·All right.
·9· · · · · · · ·And the constraints that are
10· · reflected in this data that you talk about,
11· · and I believe it's footnote 118 on page 27,
12· · if you don't have it in front of you, the
13· · literature has looked at constraints like
14· · the availability of stocks to borrow too
15· · short as well as the loan fees for
16· · borrowing the stock, right?
17· · · · ·A· · ·Yes.· Those are some of the
18· · measures, the more nuanced measures that
19· · have been used.
20· · · · ·Q· · ·And in the real world, those are
21· · practical constraints on the ability to
22· · engage in short selling, right?
23· · · · ·A· · ·Yes, they are.
24· · · · ·Q· · ·And you did not analyze those
25· · constraints for RAI because you couldn't
·1· · · · · · · · · ·A. Shivdasani
·2· · get access to the data for litigation
·3· · purposes, right?
·4· · · · ·A· · ·Yes.· I did not analyze those
·5· · constraints because those constraints using
·6· · the metrics that I talk about in my report,
·7· · because that data was unavailable, but I
·8· · was able to do other analysis that led me
·9· · to arrive at a conclusion about whether or
10· · not these were meaningful constraints for
11· · RAI investors.
12· · · · ·Q· · ·Right.
13· · · · · · · ·Well, so paragraphs 83 through
14· · 86 you discuss the constraint of appearing
15· · on the restricted list from the New York
16· · Stock Exchange, right?
17· · · · ·A· · ·That is correct.· That's what
18· · those paragraphs talk.
19· · · · ·Q· · ·That's the only specific
20· · constraint that you analyzed, right?
21· · · · ·A· · ·Well, I did analyze constraints
22· · more broadly than that by looking at actual
23· · trading pattern around the Lorillard merger
24· · because that trading pattern is very
25· · informative about the degree of
·1· · · · · · · · · ·A. Shivdasani
·2· · constraints.
·3· · · · · · · ·Had other constraints been very
·4· · binding, I would have not found the
·5· · patterns that I observed around the
·6· · Lorillard merger.
·7· · · · · · · ·So I was able to conduct other
·8· · analyses that were very informative about
·9· · these constraints even though I could not
10· · observe some of these nuanced measures
11· · directly.
12· · · · ·Q· · ·When did the Lorillard
13· · transaction close?
14· · · · ·A· · ·I talk about it in my report.
15· · It closed, I believe it was somewhere
16· · around June of 2015, if memory serves me
17· · right.
18· · · · ·Q· · ·I agree with your recollection.
19· · · · ·A· · ·Okay.
20· · · · ·Q· · ·That was approximately 2 years
21· · before the RAI BAT merger closed, correct?
22· · · · ·A· · ·But less than that, from the
23· · time when the BAT merger was initially
24· · announced.
25· · · · ·Q· · ·About a year before?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Right.
·3· · · · ·Q· · ·The merger was initially
·4· · announced?
·5· · · · ·A· · ·That is correct.
·6· · · · ·Q· · ·The next section of your report
·7· · the heading is Changes in Reynolds' Stock
·8· · Price Do Not Display Predictability.
·9· · · · · · · ·Do you see that?
10· · · · ·A· · ·Yes, I do.
11· · · · ·Q· · ·And in the section of your
12· · report you discuss a test you conducted
13· · that was intended to examine whether new
14· · information is incorporated into Reynolds'
15· · stock price relatively quickly, right?
16· · · · ·A· · ·That is correct.
17· · · · ·Q· · ·And as I understand the test --
18· · and correct me if I'm wrong, because it's a
19· · better-than-average possibility that I just
20· · didn't understand it -- was that you looked
21· · at the average daily and weekly stock
22· · returns for Reynolds during the pre-merger
23· · period and looked to see if they were
24· · correlated?
25· · · · ·A· · ·No.· I looked at what's called
·1· · · · · · · · · ·A. Shivdasani
·2· · auto correlation in daily and weekly stock
·3· · returns.· I was not looking at the
·4· · correlation between daily and weekly stock
·5· · returns.
·6· · · · · · · ·So when considering daily stock
·7· · returns, I considered whether the return on
·8· · a particular day was correlated with the
·9· · return the prior day, and the day prior,
10· · and the day prior.· I'll look at auto
11· · correlations and I did that both for daily
12· · returns, as well as for weekly returns.
13· · · · ·Q· · ·The test did not focus on the
14· · dates of the events that you selected for
15· · your event study, right?
16· · · · ·A· · ·No, it did not and it should not
17· · have.
18· · · · ·Q· · ·If you look at the auto
19· · correlation of the daily returns, we'll
20· · take that across the entire pre-merger
21· · period --
22· · · · ·A· · ·That is correct.
23· · · · ·Q· · ·-- and without with regard to
24· · when value relevant information is being
25· · released, right?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Well, I did not segregate the
·3· · days according to value relevant
·4· · information.· That's not the typical
·5· · approach that's taken in the literature.
·6· · · · · · · ·So I conducted this test using
·7· · the typical approach that is done in the
·8· · literature, is to test, which is just to
·9· · test for auto correlation and returns over
10· · the period of time.
11· · · · ·Q· · ·You are not offering the opinion
12· · that the pre-announcement trading price of
13· · Reynolds' stock is equal to the fair value
14· · of Reynolds as to the valuation date,
15· · right?
16· · · · ·A· · ·I am not offering that opinion.
17· · · · ·Q· · ·And you're not offering any
18· · opinion about how the pre-announcement
19· · trading price should be adjusted to derive
20· · the fair value of Reynolds as of the
21· · valuation date, right?
22· · · · ·A· · ·That was not part of my
23· · assignment and I did not form any opinions
24· · on that, no.
25· · · · ·Q· · ·Also in front of you and marked
·1· · · · · · · · · ·A. Shivdasani
·2· · as Exhibit 1301 should be your rebuttal
·3· · report?
·4· · · · ·A· · ·Yes.
·5· · · · ·Q· · ·And just for the record, go
·6· · ahead and confirm that that's, in fact, a
·7· · copy of your rebuttal and it includes the
·8· · relevant exhibits or appendices or both,
·9· · I'm not sure how -- if they're called
10· · exhibits or appendices.· It looks like
11· · they're both actually.
12· · · · ·A· · ·Yes, it appears to be.
13· · · · ·Q· · ·All right.
14· · · · · · · ·And your rebuttal report is
15· · limited to a single issue, namely to review
16· · our opening valuation report and evaluate
17· · whether there is economic evidence
18· · suggesting that BAT's 42 percent stake in
19· · Reynolds had a negative effect on Reynolds'
20· · stock price prior to the announcement of
21· · the BAT merger proposal.
22· · · · · · · ·(Whereupon, the requested
23· · · · ·portion was read back by the Court
24· · · · ·Reporter.)
25· · · · ·A· · ·Yes, that is correct.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·I would, just for clarification
·3· · on that, you referred to your opening
·4· · report as I believe in that question, and
·5· · some of my opinions make reference to
·6· · valuations conducted in two of the opening
·7· · reports.
·8· · · · · · · ·But you're right, as a general
·9· · matter that is what my opinion is limited
10· · to, to that, on that topic, although I do
11· · make reference to more than one report
12· · offered in this case.
13· · · · ·Q· · ·Reynolds itself in its annual
14· · reports on Form 10-K identified BAT's
15· · significant beneficial interest in Reynolds
16· · as a factor that could have potentially
17· · negative effects on Reynolds' stock price,
18· · right?
19· · · · ·A· · ·I believe there was discussion
20· · around that in the risk factors discussion,
21· · yes, but that was not a focus of my
22· · investigation.
23· · · · ·Q· · ·Did you perform any analysis to
24· · determine the impact of those disclosures
25· · on Reynolds' stock price?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Well, I reviewed the evidence
·3· · that Dr. Zmijewski presented.· I didn't do
·4· · an independent evaluation of those risk
·5· · factors, if that was your question.
·6· · · · · · · ·I hope I answered your question.
·7· · · · ·Q· · ·Did you attempt to quantify the
·8· · impact of the risk factor disclosures
·9· · regarding BAT's 42 percent stake in
10· · Reynolds, on Reynolds' stock price?
11· · · · ·A· · ·No, I did not conduct any
12· · independent attempted quantification.
13· · · · ·Q· · ·If you turn to paragraph 11 of
14· · your rebuttal report, there in the second
15· · sentence you criticize Dr. Zmijewski for
16· · failing to provide direct empirical
17· · evidence that the deal price was adversely
18· · impacted by the competitive bidding process
19· · or the lack thereof.
20· · · · · · · ·Do you see that?
21· · · · ·A· · ·Yes, I do.
22· · · · ·Q· · ·Out of curiosity, other than
23· · having a time machine creating a scenario
24· · where there was no 42 percent stockholder
25· · of Reynolds and there was a competitive
·1· · · · · · · · · ·A. Shivdasani
·2· · bidding process for Reynolds, how could
·3· · anyone provide direct empirical evidence
·4· · for that proposition?
·5· · · · · · · ·THE WITNESS:· Could you please
·6· · · · ·repeat that question?
·7· · · · · · · ·(Whereupon, the requested
·8· · · · ·portion was read back by the Court
·9· · · · ·Reporter.)
10· ·BY MR. SHINDEL:
11· · · · ·Q· · ·That should have been short of
12· · having a time machine.
13· · · · ·A· · ·Let me put it this way.· If one
14· · is going to make a conclusion that in this
15· · matter BAT's 42 percent stake adversely
16· · impacted in this case the competitive
17· · bidding process, I think there is analysis
18· · that could be relevant to an assessment of
19· · that conclusion.· I did not see any
20· · analysis of that kind and that's what I'm
21· · responding to.
22· · · · · · · ·There are studies that attempt
23· · to quantify the impact of toeholds on the
24· · bidding process, there is a literature on
25· · this, and I think there are techniques that
·1· · · · · · · · · ·A. Shivdasani
·2· · have been used.· And I saw no attempt to
·3· · use any of that techniques, that
·4· · literature, and to provide evidence that
·5· · would be relevant to that assessment.
·6· · · · ·Q· · ·Are you aware of what were
·7· · Reynolds' financial advisors told about the
·8· · impact of BAT's 42 percent stake on any
·9· · competitive bidding process?
10· · · · ·A· · ·It was not a focus of my
11· · investigation or I was not asked to offer
12· · opinions on that.· I was asked to review
13· · Dr. Zmijewski's report.
14· · · · ·Q· · ·Are you aware of what the
15· · financial advisors told Reynolds about the
16· · impact of BAT's stake on the potential for
17· · competitive bidding process?
18· · · · ·A· · ·Well, I mean I'm aware what the
19· · financial advisor said in this case.· I'm
20· · aware they said there was, you know,
21· · several advisors opined that this was a
22· · fair offer.· I mean I've read the stuff in
23· · the financial advisor's report.· I've read
24· · sort of what their, you know, some of the
25· · things that they said on this issue.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·My assignment here was not to
·3· · review the financial advisors' reports, but
·4· · to assess Dr. Zmijewski's report.· So
·5· · that's what I'm talking about in this --
·6· · but yes, I am aware of what they said.
·7· · · · ·Q· · ·All right.· What did they say?
·8· · · · ·A· · ·Well, they concluded that -- I
·9· · think that several advisors concluded that
10· · the offers were fair.· I think that's what
11· · I recall.
12· · · · ·Q· · ·What do you recall about the
13· · question that I asked you, which is what
14· · they had to say about the impact of BAT's
15· · 42 percent stake on a competitive bidding
16· · process?
17· · · · ·A· · ·I don't have a complete
18· · recollection of that.· I know that some of
19· · the materials produced by financial
20· · advisors made reference to it.· I don't
21· · have a complete recollection of all of the
22· · things that they said.· But I know this was
23· · a topic that some of the advisors talked
24· · about.
25· · · · ·Q· · ·Do you recall anything about
·1· · · · · · · · · ·A. Shivdasani
·2· · what they had to say about it?
·3· · · · ·A· · ·You know, I think my general
·4· · recollection is that they pointed out that
·5· · there would be a limited universe of other
·6· · buyers.· Exactly the language and how
·7· · limited or the extent of the impact, I
·8· · don't know, but I think there was some -- I
·9· · recall reading some discussion around that.
10· · · · · · · ·Again, this was not a focus of
11· · my investigation, but I am aware that some
12· · of the advisors talked about this issue.
13· · · · ·Q· · ·Is it your view that the
14· · competitive bidding process is not hampered
15· · by having a 42 percent stockholder of a
16· · corporation announce that it is not a
17· · seller under any circumstances?
18· · · · ·A· · ·No, that is not my view and
19· · that's not an opinion that I'm offering
20· · here, but I think that, you know, the
21· · answer, that is situation specific.· It
22· · would depend upon the number of natural
23· · buyers for a business.· It would depend on,
24· · you know, who would otherwise be interested
25· · and able to consume, to consummate such a
·1· · · · · · · · · ·A. Shivdasani
·2· · transaction.· So it would depend upon a lot
·3· · of factors.
·4· · · · · · · ·I didn't see any analysis in
·5· · Dr. Zmijewski's report about all of the
·6· · factors.· But I'm not, I'm not making the
·7· · contention or offering the opinion that I
·8· · think you raised in your question.
·9· · · · ·Q· · ·Did you analyze the other
10· · potential bidders for Reynolds?
11· · · · · · · ·MS. VALENTE:· Objection.  I
12· · · · ·think we're getting pretty far beyond
13· · · · ·his rebuttal report.
14· · · · ·A· · ·No.· As I mentioned, I analyzed
15· · the evidence that Dr. Zmijewski presented
16· · and as I explain in my report I also looked
17· · at whether there was any support for the
18· · proposition that this was depressing, the
19· · 42 percent was depressing BAT's stock price
20· · in the analyst's commentary, and that's
21· · what my opinions are based on.
22· · · · ·Q· · ·Is it your opinion that a
23· · competitive bidding process does not
24· · increase acquisition premia?
25· · · · ·A· · ·I think that would depend on the
·1· · · · · · · · · ·A. Shivdasani
·2· · circumstances.· I am not offering that
·3· · opinion.
·4· · · · · · · ·One of the studies that
·5· · Dr. Zmijewski cites shows that acquisition
·6· · premia in situations where there were
·7· · single bidder versus multiple bidders,
·8· · there was not a meaningful difference
·9· · between that.
10· · · · · · · ·There are other reports and
11· · other studies that he cites that do show a
12· · difference, but that difference is nowhere
13· · in the range of magnitudes that would be
14· · required to reconcile Dr. Zmijewski's
15· · position with his valuation.
16· · · · · · · ·So those are the opinions that
17· · I'm offering.
18· · · · ·Q· · ·Is it your opinion that the lack
19· · of a competitive bidding process is
20· · irrelevant in evaluating whether the deal
21· · price is indicative of fair value in an
22· · appraisal?
23· · · · · · · ·Is it your opinion that the lack
24· · of a competitive bidding process is
25· · irrelevant in evaluating whether the deal
·1· · · · · · · · · ·A. Shivdasani
·2· · price is indicative of fair value in an
·3· · appraisal?
·4· · · · · · · ·MS. VALENTE:· Objection.
·5· · · · ·A· · ·I have no opinion on that
·6· · matter.
·7· · · · ·Q· · ·Your opening report, as we
·8· · discussed earlier, relied extensively on
·9· · three Delaware judicial decisions, rights?
10· · · · ·A· · ·It relied on those decisions in
11· · coming up with the factors that I believe
12· · the courts have considered, yes, that is
13· · correct.
14· · · · ·Q· · ·All right.
15· · · · · · · ·And in each of those decisions
16· · the virtues of a competitive bidding
17· · process were discussed, right?
18· · · · ·A· · ·It's possible that they were.
19· · · · ·Q· · ·You don't recall?
20· · · · ·A· · ·I don't recall off the top of my
21· · head whether they were in all of them, but
22· · it's possible.
23· · · · · · · ·I did see discussions around
24· · deal process that was not a focus of my
25· · analysis here.· I was asked specifically to
·1· · · · · · · · · ·A. Shivdasani
·2· · look at Dr. Zmijewski's report and assess
·3· · this statement that he made.
·4· · · · ·Q· · ·In paragraph 11 of your rebuttal
·5· · report you assert Dr. Zmijewski does not
·6· · provide evidence to suggest that the
·7· · presence of additional bidders standing
·8· · alone would bridge the gap between deal
·9· · price and his valuation opinion, is that
10· · right?
11· · · · · · · ·THE WITNESS:· Could you repeat
12· · · · ·the question, please?
13· · · · · · · ·(Whereupon, the requested
14· · · · ·portion was read back by the Court
15· · · · ·Reporter.)
16· · · · ·A· · ·Unfortunately, that question is
17· · not really clear to me.· There's either
18· · some part I missed -- I don't understand
19· · the standing alone.
20· · · · · · · ·If you could please clarify that
21· · for me, that would be very helpful.
22· · · · ·Q· · ·The bottom of page 4, paragraph
23· · 11, you have a sentence that begins the
24· · academic research he cites.
25· · · · · · · ·Do you see that?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·Yes, I do.
·3· · · · ·Q· · ·All right.
·4· · · · · · · ·Go ahead and read that sentence.
·5· · I'm not going to read it into the record.
·6· · · · ·A· · ·Right.· The academic research
·7· · that he cites --
·8· · · · · · · ·MS. VALENTE:· You don't have to
·9· · · · ·read it.
10· · · · · · · ·THE WITNESS:· Oh, sorry.
11· ·BY MR. SHINDEL:
12· · · · ·Q· · ·No, just read it yourself.
13· · · · ·A· · ·Oh, read it myself.
14· · · · ·Q· · ·Have it in mind.· That's what
15· · I'm focusing on.
16· · · · ·A· · ·Oh, understood.· I have read
17· · that sentence, yes.
18· · · · ·Q· · ·So maybe I misunderstood your
19· · report, but what I understood you to mean
20· · by that sentence is that Dr. Zmijewski
21· · cites certain academic studies that
22· · suggests there's a premium inherent in
23· · there being a competitive bidding process
24· · and I guess one that doesn't, right.· Two
25· · studies suggest there is a premium just by
·1· · · · · · · · · ·A. Shivdasani
·2· · virtue of having multiple bidders.· One of
·3· · them should have no difference, right?
·4· · · · ·A· · ·Right.
·5· · · · ·Q· · ·And what you're saying here is
·6· · even if you credit that there is such a
·7· · premium, that premium is not enough to
·8· · bridge the gap between the deal price and
·9· · Dr. Zmijewski's valuation.· Is that not
10· · what you're saying here?
11· · · · ·A· · ·That is exactly what I'm saying,
12· · yes.
13· · · · ·Q· · ·Okay.
14· · · · · · · ·But Dr. Zmijewski never opines
15· · that the lack of competitive bidding is the
16· · sole reason for the difference between the
17· · deal price and his valuation, right?
18· · · · ·A· · ·I don't believe he does.
19· · · · ·Q· · ·So you're defeating a straw man
20· · here?
21· · · · ·A· · ·No.· I am just pointing out here
22· · that even if one were to accept that a lack
23· · of Dr. Zmijewski's position, that a lack of
24· · a bidding process or the presence of
25· · multiple bidders would have resulted in a
·1· · · · · · · · · ·A. Shivdasani
·2· · higher price if, as I understood
·3· · Dr. Zmijewski's report to read, that the
·4· · gap between his valuation and the
·5· · unaffected stock price, or the deal price,
·6· · was so large that the studies that he cites
·7· · do not support a gap of that magnitude --
·8· · that's all I'm saying.
·9· · · · ·Q· · ·But as I thought we just
10· · established, it is not his opinion that the
11· · lack of competitive bidding is the sole
12· · reason for the difference between his
13· · valuation and the deal price?
14· · · · ·A· · ·As I said, I've not evaluating
15· · other aspects of his report.· I was asked
16· · to focus on this and it's possible what
17· · you're suggesting is an appropriate
18· · interpretation of his report.· That was not
19· · a focus of my analysis.
20· · · · ·Q· · ·Do you have a view from a
21· · finance perspective whether an auction
22· · scenario, what's sometimes been referred to
23· · as auction tension, is beneficial in
24· · getting an increased price at the end of
25· · the deal process?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·MS. VALENTE:· Objection.
·3· · · · ·A· · ·Do I have an opinion?· I think
·4· · as a matter of opinion, which I'm not
·5· · offering in this case, but just as a --
·6· · based on my experience, it can be helpful.
·7· · The degree to which it's helpful is very
·8· · fact-specific.· There can be situations
·9· · where a buyer chooses to make a very
10· · attractive offer simply so that they would
11· · not have to compete with other bidders.
12· · · · · · · ·So there's -- I don't disagree
13· · with that proposition, but I would add that
14· · it's very fact and situation-specific.· It
15· · depends on the nature of the buyer, the
16· · industry, the number -- who is interested,
17· · the target.· So I think a lot of factors
18· · come into that assessment.
19· · · · ·Q· · ·In paragraph 12 of your
20· · rebuttal, you cite to various studies
21· · indicating that, or that you contend
22· · indicate that the stock price of a target
23· · firm reacts positively to a shareholder
24· · getting a significant toehold, is that
25· · right.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·That is correct.· That is what
·3· · the academic literature has found.
·4· · · · ·Q· · ·And the main theory behind that
·5· · is that the purchase of the toehold is a
·6· · precursor to an ultimate acquisition
·7· · proposal?
·8· · · · · · · ·THE WITNESS:· Could you repeat
·9· · · · ·the question, please?
10· · · · · · · ·(Whereupon, the requested
11· · · · ·portion was read back by the Court
12· · · · ·Reporter.)
13· · · · ·A· · ·Could you clarify by what you
14· · mean by the main theory, the main theory
15· · according to these papers or --
16· · · · ·Q· · ·Right.
17· · · · ·A· · ·The way I would sort of phrase
18· · it is these papers point to the fact that a
19· · toehold often leads to a subsequent
20· · acquisition and that the expectation of
21· · that subsequent acquisition results in a
22· · positive response of the stock price at the
23· · time that the toehold is announced, and
24· · that is one of the factors, but not
25· · necessarily the only factor that leads to
·1· · · · · · · · · ·A. Shivdasani
·2· · the stock price appreciating when a toehold
·3· · is announced.· That's what I'm referring to
·4· · in this part of my report.
·5· · · · ·Q· · ·All right.
·6· · · · · · · ·And in paragraph 15 of your
·7· · report, you quote a variety of analysts
·8· · from various points in time discussing the
·9· · possibility of BAT acquiring Reynolds,
10· · right?
11· · · · ·A· · ·That is correct.
12· · · · ·Q· · ·And the consensus of the
13· · analysts that you quote is that ultimately
14· · an acquisition was logical, but there would
15· · not be an acquisition in the near term,
16· · right?
17· · · · ·A· · ·I think -- I would say -- I
18· · guess if I were to, at the risk of omitting
19· · important detail and nuance in individual
20· · reports, if I were to characterize the
21· · nature of the analyst's commentary, yes,
22· · that is what it reflects, that most of them
23· · felt that this increased the likelihood --
24· · that there was a likelihood that at some
25· · point in time BAT would be a buyer of the
·1· · · · · · · · · ·A. Shivdasani
·2· · business and for the most part analysts did
·3· · not expect an offer to be imminent.
·4· · · · ·Q· · ·How long had BAT had a 42
·5· · percent stake in Reynolds as of the date of
·6· · its acquisition proposal announcement?
·7· · · · ·A· · ·Well, I believe I talk about in
·8· · my report, I think if memory serves me
·9· · right it was approximately 2004 when it
10· · initially acquired that stake.· So it would
11· · be approximately 16 years -- sorry, yeah --
12· · 12 years.
13· · · · ·Q· · ·The analyst consensus, such as
14· · it is -- I think you kind of wanted to
15· · quibble with that term and I'm not trying
16· · to -- I'll accept the description in your
17· · prior answer -- but as a shorthand for it
18· · to not restate the whole thing I'm going to
19· · use the term consensus.
20· · · · ·A· · ·Okay, that's fine.
21· · · · ·Q· · ·The analyst's consensus about an
22· · acquisition proposal not being imminent
23· · turned out to be wrong, correct?
24· · · · ·A· · ·That is correct.· I think many
25· · analysts found that to be a surprise.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·Does that suggest anything to
·3· · you about the reliability of the analysts
·4· · who were covering Reynolds?
·5· · · · ·A· · ·No.· I think it suggests that
·6· · this was, the timing of the event was a
·7· · surprise to the market.· I think that's
·8· · what it suggests.
·9· · · · · · · ·It doesn't mean that the
10· · analysts were reliable.· I think the
11· · literature hasn't shown or ever claimed
12· · that analysts perform a role by accurately
13· · predicting the timing of takeovers.
14· · · · · · · ·So, you know, that doesn't lead
15· · me to make any assessment about the
16· · reliability of analysts.
17· · · · ·Q· · ·Have you reviewed the Yilmaz
18· · rebuttal report?
19· · · · ·A· · ·Yes, I have.
20· · · · ·Q· · ·Has the Yilmaz rebuttal report
21· · caused you to reevaluate any of your
22· · opinions?
23· · · · ·A· · ·Not at all.
24· · · · ·Q· · ·Do you intend to offer any
25· · opinions regarding the Yilmaz rebuttal
·1· · · · · · · · · ·A. Shivdasani
·2· · report at trial?
·3· · · · ·A· · ·I don't know, if I'm asked to,
·4· · but I mean Yilmaz I think incorrectly
·5· · criticizes some aspects of my report and
·6· · it's possible that I may offer opinions
·7· · related to his criticisms, I don't know,
·8· · but they will be on topics that are
·9· · contained in my reports as I expect them.
10· · That's my best expectation at this point.
11· · · · ·Q· · ·Which criticisms of your report
12· · that Dr. Yilmaz offers do you believe are
13· · inaccurate?
14· · · · ·A· · ·I believe all of them.· I mean,
15· · I noticed Yilmaz criticizes me for several
16· · things.· There's not -- I believe he has
17· · reached incorrect opinions on all of those
18· · criticisms.
19· · · · ·Q· · ·So there's nothing in the Yilmaz
20· · rebuttal report that you agree with?
21· · · · ·A· · ·That's not what I said.
22· · · · · · · ·I mean he makes statements about
23· · the efficient market hypothesis and so
24· · forth that I don't have issue with, but
25· · there are specific issues that he raises,
·1· · · · · · · · · ·A. Shivdasani
·2· · for example, with my event study or other
·3· · aspects that I have disagreements with.
·4· · · · · · · ·MR. SHINDEL:· Mark that as the
·5· · · · ·next one.
·6· · · · · · · ·(Whereupon, Exhibit 1303,
·7· · · · ·Rebuttal Report of Bilge Yilmaz,
·8· · · · ·marked for Identification, as of this
·9· · · · ·date.)
10· ·BY MR. SHINDEL:
11· · · · ·Q· · ·I just marked and placed in
12· · front of you Dr. Yilmaz's rebuttal report.
13· · · · · · · ·If you could turn to page 5
14· · paragraph 15 and here he's discussing
15· · whether the pre-announcement trading price
16· · of Reynolds' stock is an appropriate
17· · measure of fair value.
18· · · · · · · ·Do you have any view as to his
19· · conclusions in that section of the report?
20· · · · ·A· · ·I have no opinions on this
21· · topic.
22· · · · · · · ·Actually, I need to clarify that
23· · answer.· When I said no opinions on this
24· · topic, I'm referring to his headline
25· · conclusion about whether or not Reynolds'
·1· · · · · · · · · ·A. Shivdasani
·2· · common stock is an appropriate measure of
·3· · the fair value.
·4· · · · · · · ·But this section of his report
·5· · on paragraph 17, for example, at the end
·6· · has a statement that says Professor
·7· · Zmijewski did not perform his event studies
·8· · correctly.
·9· · · · · · · ·Yes, I do have issue with that.
10· · So I just want to clarify what I meant by
11· · topic.· When I was referring to topic, I
12· · was referring to the concept of whether or
13· · not fair value and common stock price
14· · should be equated.
15· · · · ·Q· · ·Fair enough.
16· · · · · · · ·In this paragraph 17, Dr. Yilmaz
17· · indicates that the event studies that you
18· · perform do not demonstrate that Reynolds'
19· · stock price was a relevant indicator of
20· · fair value.
21· · · · · · · ·Do you see that, in paragraph
22· · 17?
23· · · · ·A· · ·Yes, I see that.
24· · · · ·Q· · ·Do you agree with that
25· · statement?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·A· · ·I have no opinion on that
·3· · statement.
·4· · · · ·Q· · ·You neither agree nor disagree?
·5· · · · ·A· · ·No.· My assignment was not to
·6· · evaluate the fair value.· So I'm not
·7· · offering any opinions on that issue.
·8· · · · ·Q· · ·All right.
·9· · · · · · · ·Paragraph 18, Dr. Yilmaz notes
10· · that there were important facts and
11· · circumstances about Reynolds on the merger
12· · date that were not publicly known as of the
13· · date of the BAT proposal announcement.
14· · · · · · · ·Do you have any opinion on that
15· · conclusion?
16· · · · ·A· · ·No.· It's not an issue I was
17· · asked to investigate in my report.· It was
18· · not part of my assignment and I have no
19· · opinions on that.
20· · · · ·Q· · ·If you go to page 11, the
21· · subheading there, the relevance of the
22· · efficient market hypothesis to valuation,
23· · and that runs from paragraph 30 to 36?
24· · · · ·A· · ·To 36, yes.
25· · · · ·Q· · ·Are there any conclusions
·1· · · · · · · · · ·A. Shivdasani
·2· · offered in this section of the report that
·3· · you have an opinion on?
·4· · · · · · · ·MS. VALENTE:· Do you want him to
·5· · · · ·go line by line and paragraph by
·6· · · · ·paragraph?
·7· · · · ·A· · ·Agreeing as well as
·8· · disagreeing -- you know, I mean --
·9· · · · · · · ·MR. SHINDEL:· I mean I'm just
10· · · · ·trying to find out, you know, the
11· · · · ·witness has indicated he might come to
12· · · · ·trial and testify about some things if
13· · · · ·asked to do so.· Seemingly, he hasn't
14· · · · ·yet been asked.· So I'm just trying to
15· · · · ·not get surprised at trial.
16· · · · · · · ·MS. VALENTE:· I understand.
17· · · · ·Just so he knows how to answer you, do
18· · · · ·you want him to say sentence by
19· · · · ·sentence or paragraph by paragraph?
20· · · · · · · ·MR. SHINDEL:· No.
21· · · · · · · ·MS. VALENTE:· Just trying to
22· · · · ·make it easier for everyone.
23· ·BY MR. SHINDEL:
24· · · · ·Q· · ·We can do this the most painful
25· · way, if that's the way we want to do it.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·So the first sentence of
·3· · paragraph 30, do you have an opinion about
·4· · that sentence?
·5· · · · ·A· · ·You know, let me -- would it be
·6· · helpful if I try to answer your question in
·7· · a different way and let me see if that's,
·8· · if that's responsive and then we'll come
·9· · back and talk specifically about this?
10· · · · · · · ·Professor Yilmaz makes specific
11· · criticisms about the analysis that I have
12· · conducted, decisions with respect to event
13· · studies, the methodology and so forth that
14· · we have reviewed.· I don't agree with those
15· · criticisms.
16· · · · · · · ·His report touches on many other
17· · issues that are not part of my assignment.
18· · I don't intend to talk about or offer
19· · opinions on issues that were not part of my
20· · assignment unless they somehow become
21· · relevant in addressing specific criticisms
22· · that Professor Yilmaz makes.
23· · · · · · · ·Now, with that, we can go
24· · through this sentence by sentence.· You
25· · know, I see this to be a discussion of the
·1· · · · · · · · · ·A. Shivdasani
·2· · relevant, relevance of the efficient market
·3· · hypothesis to valuation.· My report
·4· · obviously talks at length about the
·5· · efficient market hypothesis.· But I am not
·6· · offering any opinions on the fair value.
·7· · · · ·Q· · ·All right.· Good.· We can skip
·8· · through to section 3, subsection 3 here on
·9· · page 15, and this goes from paragraphs 37
10· · to 43.· The headline is:· Discussing the
11· · Limitations of Event Studies in the
12· · Semi-Strong Form of the Efficient Market
13· · Hypothesis.
14· · · · ·A· · ·Uh-huh.
15· · · · ·Q· · ·Now, flip through this section,
16· · these paragraphs, review it to yourself.
17· · Take as much time as you need.· We don't
18· · have to go through sentence by sentence.
19· · But let me know if there is anything in
20· · here that you disagree with and intend to
21· · testify about your disagreement at trial.
22· · · · ·A· · ·I mean this is a pretty long
23· · section, so maybe if we can break it up, I
24· · can start -- I mean, yes, there are
25· · sections in here that I do disagree with.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·So I'll start with, I will start
·3· · with the bottom part of paragraph 37.
·4· · · · ·Q· · ·Okay.
·5· · · · ·A· · ·Where he says:· "Put simply, in
·6· · this case Professor Gompers and Shivdasani
·7· · have inappropriately relied on a test for
·8· · one thing to draw conclusions about a
·9· · completely unrelated thing."
10· · · · · · · ·I am not drawing conclusions
11· · about fair value.· I have not offered any
12· · opinions.· I believe Yilmaz's statement
13· · here is factually incorrect.· So that would
14· · be the first sentence that I disagree with.
15· · · · ·Q· · ·Okay.
16· · · · ·A· · ·Take a look at footnote 37, and
17· · I believe that footnote 37 is an incomplete
18· · and potentially misleading statement.
19· · · · · · · ·And to the extent it relates to
20· · the semi-strong form of the efficient
21· · market hypothesis, which I do talk about in
22· · my report, that would be another area where
23· · I would at least disagree with the
24· · statement as a complete characterization of
25· · the facts and how he has represented it.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·And what do you -- what about
·3· · that footnote misrepresents the facts as
·4· · you understand them?
·5· · · · ·A· · ·I think what Professor Yilmaz is
·6· · overlooking is an enormous body of
·7· · literature that points to the problems with
·8· · the kinds of tests that he's talking about,
·9· · these trading strategies, and the
10· · interpretation of the evidence of abnormal
11· · or arbitrage profits.
12· · · · · · · ·He has very selectively taken a
13· · position on this that I believe
14· · mischaracterizes a lot of the analysis on
15· · this position.
16· · · · · · · ·This literature clearly
17· · acknowledges that these types of tests are
18· · not direct tests of the efficient market
19· · hypothesis because they represent what's
20· · known as joint tests of both the efficient
21· · market hypothesis and the underlying asset
22· · pricing model.· That's a very important
23· · nuance and distinction that Mr. Yilmaz,
24· · Professor Yilmaz is not, I think,
25· · representing here.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·You know, on paragraph 39, there
·3· · may be certain aspects of this that I
·4· · disagree with.· I think he's making a lot
·5· · of statements in this paragraph.· And what
·6· · Professor Yilmaz is, I think, not
·7· · acknowledging and by failure to
·8· · acknowledge, I think, is reaching a
·9· · conclusion that I think is relevant to the
10· · assessment of event studies, he is implying
11· · that event studies are not relevant to the
12· · determination of values in efficient
13· · markets.· And there is a substantial body
14· · of literature that argues that the
15· · efficient market hypothesis is best tested
16· · by event study analysis, and that in
17· · efficient markets all of the information is
18· · reflected in the public stock price.
19· · · · · · · ·It's hard for me to go sentence
20· · by sentence to say what I agree and
21· · disagree with because he's also got issues
22· · about fair value indicated that I'm not
23· · offering opinions on.
24· · · · · · · ·But I do believe he is reaching
25· · very strong conclusions in some of what
·1· · · · · · · · · ·A. Shivdasani
·2· · he's applying, although it's hard for me to
·3· · point to a specific sentence.
·4· · · · ·Q· · ·That's fair.· I've got the
·5· · flavor of your thoughts on that section.
·6· · · · · · · ·We can -- let's go to page 26,
·7· · paragraph 61, which from your prior answers
·8· · I take is the real heart of your
·9· · disagreement with Professor Yilmaz.
10· · · · ·A· · ·Yes.
11· · · · ·Q· · ·All right.
12· · · · · · · ·So you go to the next page,
13· · paragraph 63, Professor Yilmaz indicates
14· · that you appear to have cherrypicked
15· · certain events or information and lists
16· · several examples.
17· · · · · · · ·I assume you disagree with that
18· · characterization?
19· · · · ·A· · ·Absolutely.
20· · · · ·Q· · ·Why do you disagree?
21· · · · ·A· · ·Because it is a factually
22· · incorrect statement.· I picked the list
23· · of -- the types of events I considered
24· · based upon the types of events that are
25· · listed in some of the most prominent
·1· · · · · · · · · ·A. Shivdasani
·2· · textbooks in corporate finance as examples
·3· · of events to be used in event studies.  I
·4· · cite that in my report.
·5· · · · · · · ·I think, as I mentioned before,
·6· · they talk about earnings announcements,
·7· · they talk about equity issuances.· So I did
·8· · not cherrypick them.· I based them on a
·9· · wide body of literature of events that have
10· · been used in event studies and event
11· · studies in the context of assessing market
12· · efficiency.
13· · · · ·Q· · ·All right.
14· · · · · · · ·Paragraph 64 on the next page,
15· · the issue here -- I'm paraphrasing -- is
16· · how you went about isolating the different
17· · information events under consideration.
18· · · · ·A· · ·Right.
19· · · · ·Q· · ·I assume you disagree with the
20· · discussion in paragraph 64 of the Yilmaz
21· · rebuttal report?
22· · · · ·A· · ·Here -- not entirely.· There are
23· · specific sentences that I agree with.
24· · · · · · · ·I agree with the fact that he
25· · says that Professor Shivdasani correctly
·1· · · · · · · · · ·A. Shivdasani
·2· · recognizes that there are at least two
·3· · information events on that day.
·4· · · · · · · ·I agree with the fact that it
·5· · is -- that the complexity -- that this is
·6· · complex, that the treatment of this is
·7· · complicated.· These are all issues I point
·8· · out in my report.
·9· · · · · · · ·However, he seems to suggest a
10· · solution that I did not conduct that I
11· · completely disagree with, because a
12· · solution that he proposes in footnote 73 is
13· · not feasible.· So this is not a feasible
14· · solution for me to have adopted in the
15· · context of this analysis.· So I disagree
16· · with that.
17· · · · ·Q· · ·In paragraph 65, Professor
18· · Yilmaz discusses his own regression
19· · analysis.· Did you review that regression
20· · analysis?
21· · · · ·A· · ·I have taken a look at it, yes.
22· · · · ·Q· · ·Do you have any particular
23· · criticisms of that regression analysis?
24· · · · ·A· · ·Absolutely -- oh, of his
25· · regression analysis?
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·Yes.
·3· · · · ·A· · ·Well, where do I start?· Yes, I
·4· · do have criticisms.
·5· · · · · · · ·So Professor Yilmaz conducts his
·6· · regression analysis, seems to draw a
·7· · conclusion that somehow I did not conduct
·8· · my event study analysis appropriately.· And
·9· · the gist of his conclusion seems to be that
10· · there was a lot of variation in RAI's stock
11· · price, that is not explained by the events
12· · that I've considered.
13· · · · · · · ·That says nothing about the
14· · market efficiency of RAI's stock price, it
15· · says nothing about the validity of my event
16· · study, which are the two things that he
17· · seems to criticize as a result.
18· · · · · · · ·So my overall view on Professor
19· · Yilmaz's regression analysis is that it
20· · doesn't support the inferences that he is
21· · drawing from this and the implications that
22· · he's arriving at with respect to the
23· · analysis that I've conducted.
24· · · · ·Q· · ·In paragraph 66, Professor
25· · Yilmaz discusses what he characterizes as
·1· · · · · · · · · ·A. Shivdasani
·2· · two defects in your use of analyst
·3· · estimates.
·4· · · · · · · ·Do you see that?
·5· · · · ·A· · ·Yes, I do.
·6· · · · ·Q· · ·Do you agree with the first
·7· · criticism related to reliance on consensus
·8· · estimates and ignoring heard behavior,
·9· · timeliness and the other factors set out in
10· · that paragraph?
11· · · · ·A· · ·I think Yilmaz is really
12· · overstating these facts in this statement.
13· · I don't object to his characterization
14· · there are disagreements on analyst,
15· · obviously disagreements on timeliness.
16· · · · · · · ·So some of the things that he's
17· · talking about in this paragraph there is
18· · documented -- there's some studies that
19· · document some of these issues.
20· · · · · · · ·But, yet, reliance on consensus
21· · estimates is the accepted scientific
22· · approach to conducting an event study and
23· · to looking at the impact of earnings
24· · announcements and earnings surprises.
25· · There is an enormous body of literature
·1· · · · · · · · · ·A. Shivdasani
·2· · that uses consensus estimates and that is
·3· · exactly what I've done.
·4· · · · · · · ·Yilmaz seems to be critiquing me
·5· · on my approach by implication that I have
·6· · not considered these factors.
·7· · · · · · · ·The academic literature has
·8· · followed a wide body of accepted steps and
·9· · processes that I have followed.
10· · Disagreements among analysts can cancel
11· · out.
12· · · · · · · ·So I think there is no evidence
13· · that he is providing that any of my results
14· · are what I call biased or incorrect as of
15· · this.· And, in fact, goes on to suggest
16· · that somehow by incorporating this, I need
17· · to adopt non-standard methodologies.
18· · · · · · · ·And so I disagree with, I think,
19· · the essence of what he's suggesting and
20· · implying.· They are not studies that I'm
21· · aware of, for example, that go out and say
22· · that they account for potential sell side
23· · analyst conflicts and you remove certain
24· · analysts.
25· · · · · · · ·So I think everything that he's
·1· · · · · · · · · ·A. Shivdasani
·2· · suggesting is not conventional, it's not in
·3· · line with accepted scientific methodology,
·4· · and he is not showing that this actually
·5· · invalidates any of my conclusions.
·6· · · · ·Q· · ·You also had some discussion
·7· · about the short selling issues.· You and I
·8· · have already discussed that.
·9· · · · ·A· · ·Right.
10· · · · ·Q· · ·We're on the same page.
11· · · · ·A· · ·Okay.
12· · · · ·Q· · ·Do you currently intend to --
13· · well, strike that.
14· · · · · · · ·Have you read the Flyer opening
15· · report?
16· · · · ·A· · ·I may have glanced at it.  I
17· · don't think I've read it in any detail.
18· · · · ·Q· · ·You read the Flyer rebuttal
19· · report?
20· · · · ·A· · ·I don't know if I have or not.
21· · I think it was provided to me.· I don't
22· · believe I list it in any of the -- well,
23· · obviously, I couldn't have in the documents
24· · relied upon.· I'm not sure.· I may not
25· · have.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · ·Q· · ·Do you intend to offer any
·3· · opinions at trial related to either of the
·4· · Flyer reports?
·5· · · · ·A· · ·I don't believe so.
·6· · · · ·Q· · ·What about the Zmijewski
·7· · rebuttal report, have you read that?
·8· · · · ·A· · ·Yes, I have.
·9· · · · ·Q· · ·Do you intend to offer any
10· · opinions at trial related to that report?
11· · · · ·A· · ·Only to the extent they're
12· · related to the issues that I talk about in
13· · my opening and rebuttal reports.
14· · · · · · · ·MR. SHINDEL:· All right.  I
15· · · · ·don't have anything further at this
16· · · · ·point.
17· · · · · · · ·Folks on the phone?
18· · · · · · · ·MS. VALENTE:· Should we take
19· · · · ·that as a no?
20· · · · · · · ·MR. NEWMAN:· This is Brandon
21· · · · ·Newman.· I just have a couple of quick
22· · · · ·questions.
23· ·EXAMINATION BY
24· ·MR. NEWMAN:
25· · · · ·Q· · ·To the extent it has not already
·1· · · · · · · · · ·A. Shivdasani
·2· · been asked, are you prepared to render any
·3· · opinions with respect to the expert report
·4· · of Robert Taylor?
·5· · · · ·A· · ·Well, I -- I make reference to
·6· · Mr. Taylor's valuation in my, in one of my
·7· · reports with respect to the magnitude of
·8· · the discrepancy between his valuation and
·9· · the unaffected stock price, and I believe
10· · it was in the context of whether the 42
11· · percent stake is relevant to that
12· · discrepancy.
13· · · · · · · ·So it is possible that I may be
14· · asked to offer an opinion with respect to
15· · that as referenced in my reports and to
16· · expand on that, if necessary.
17· · · · ·Q· · ·And can you summarize for us
18· · what your opinion is on that discrepancy,
19· · in general?
20· · · · ·A· · ·If I could look at my report,
21· · that would be helpful.
22· · · · ·Q· · ·Sure.
23· · · · ·A· · ·And I'm pointing to footnote 4
24· · of my report.· As I note there, towards the
25· · end of that footnote:· "As such, any
·1· · · · · · · · · ·A. Shivdasani
·2· · discussion below regarding the magnitude of
·3· · mispricing implied by Dr. Zmijewski's
·4· · valuation also applies to Mr. Taylor's
·5· · valuation."
·6· · · · · · · ·And so the issues with which I
·7· · refer to Dr. Zmijewski's valuation in my
·8· · rebuttal report, I think that's the
·9· · footnote I would like to -- I think I hope
10· · that answers your question.
11· · · · ·Q· · ·It does, thank you.
12· · · · · · · ·And beyond footnote 4 that you
13· · just pointed out and your opinions about
14· · the discrepancy that you just testified to,
15· · is there any other aspect of Mr. Taylor's
16· · report that you intend to opine on at
17· · trial?
18· · · · ·A· · ·Not that I'm aware of at this
19· · time.
20· · · · · · · ·MR. NEWMAN:· Okay, thank you, I
21· · · · ·have nothing further.
22· · · · · · · ·MR. SHINDEL:· Jen?
23· · · · · · · ·MS. RANDOLPH:· Nothing from me,
24· · · · ·thanks.
25· · · · · · · ·MS. VALENTE:· Nothing from us.
·1· · · · · · · · · ·A. Shivdasani
·2· · · · · · · ·THE VIDEOGRAPHER:· We're off
·3· · · · ·12:45.
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